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ABSTRACT 
Environmental epidemiological studies can contribute to the development of explanatory and 
predictive models of health care access and utilization. The purpose of this dissertation is to develop 
a multidsiciplinary perspective  to integrate health services research with environmental 
epidemiology.  The context of this study was Arsenic toxicity and related skin lesions in India.  
Exposure to inorganic Arsenic in  groundwater occurs worldwide but is particularly serious in the 
Gangetic delta in the Indian subcontinent. Here, nearly 140 million people are exposed to inorganic 
arsenic exceeding 50 micrograms/liter. While exposure to high concentrations of inorganic Arsenic 
is commonly associated with arsenic caused skin lesions, other associated clinical disorders include 
cancers of skin, liver, lung, urinary bladder, and diabetes and bronchiectasis. It is believed that 
improved nutritional status through diet and micronutrient supplementation may protect against 
Arsenic toxicity and increased methylation through MMA generation may be associated with 
increased toxicity. It is unknown to what extent diet, micronutrients influence arsenic caused skin 
lesions and methylation, and in turn how methylation influences arsenic caused skin lesions or other 
diseases. From the perspective of health services research, this information is relevant for 
identifying macro and micropathways of Arsenic caused health effects from a health services 
research perspective. This also contributes to the explanatory models of health services utilization 
and access to care with environmental parameters as key variables.  
A cross sectional survey was conducted on 7683 individuals in West Bengal, India, between 
1995-1996. Nested within the survey was a case control study of 405 individuals (192 cases with 
skin lesions and 213 controls) on the association between diet, micronutrients and skin lesions. 
Information on diet was obtained with a food frequency questionnaire, blood and urine samples 
were collected from each participant for measurement of micronutrients, and urinary metabolites of 
inorganic Arsenic. A series of multivariate models were used to study the mutual association 
between diet, micronutrients, methylation and skin lesions in this population in a way to delineate 
the micro and macropathways related to clinical correlates and methylation related to arsenic 
toxicity.  
Results of multivariate analyses suggested that high dietary intake of animal protein (OR: , 95% CI: 
), dietary phosphorus (OR: , 95% CI: ), Calcium (OR: , 95% CI: ), and vitamin C (OR: , 95% CI: ) 
were associated with reduced risk of skin lesions. Asociation between methylation and skin lesions 
suggested that individuals with low InAs% (OR: , 95% CI: ) and high DMA% (OR: , 95% CI: ) 
were associated with higher risk of skin lesions. Finally, analysis of diet, micronutrients and arsenic 
methylation suggested that dietary animal protein, serum selenium, and plasma folate were 
associated with high MMA%, a factor known to be associated with cancerous health effects of 
arsenic exposure .  
These findings provide supportive evidence of the need for an interdisciplinary approach to model 
building in health services access and utilization. Environmental epidemiology is integral to the 
explanatory and predictive models of health services delivery and utilization.  
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CHAPTER 1: STATEMENT OF THE PROBLEM 
Abstract 
Health states are influenced by complex interactions between environment and genetic 
predisposition, and therefore health services, organized around provision of preventive services, 
health promotion and curative services, need to take into account the role environment plays in 
influencing health care access and utilization. However, environment also interacts in complex 
ways with biomedical and clinical factors involved in health care access and utilization. The 
purpose of this dissertation is to provide an insight into model building in health care access and 
utilization with contribution from environmental epidemiology. The complex global problem of 
arsenic toxicity (specifically in the context of Indian subcontinent) will be considered to develop a 
framework of the process incorporating environmental epidemiological studies into health services 
research  
Therefore, in this introductory chaper, the purpose is to provide an introduction to the inter-
relationship between environmental epidemiology and health services resarch. This will be done by 
discussing the epidemiology of inorganic Arsenic toxicity in the Indian subcontinent in particular in 
the context of the global problem, outline the key mechanisms of arsenic toxicity, in particular the 
biomethylaiton of arsenic, and address how  diet and micronutrient supplementation can potentially 
alter the course of the conditions and why diet and micronutrients are essential to contain the 
arsenic epidemic and how these issues are associated with health services organization and research. 
Second, based on the background research, the key research questions that connect arsenic  
epidemiology, methylation of arsenic and  mititgation of arsenic toxicity will be discussed. Finally, 
in this chapter an outline of the key issues and questions are provided, and a framework of 
presentation of the topic and subsequent chapters.  
Exposure to inorganic Arsenic occurs worldwide and is particularly serious in the Ganges delta. 
About 140 million people are exposed to high concentrations of inorganic Arsenic through 
groundwater supply. Exposure to inorganic Arsenic is associated with development of characteristic 
skin lesions, and other malignant and non-malignant conditions including bronchiectasis, and 
cancers of lung, liver, urinary bladder. Following entry into body, inorganic Arsenic undergoes a 
series of reduction and methylaiton reactions. As a result of these transformations, inorganic 
Arsenic is converted to monomethyl arsonous acid (MMA) and dimethyl arisinic acid (DMA) and 
excreted in urine. However, because of these stages of biotransformation, in presence of heavy load 
of inorganic Arsenic, deficiencies of micronutrients occur and other biological processses such as 
DNA formation and maintenance that are in turn dependent on biomethylation get affected. These 
processes result in pathological processes lead to arsenic-caused malignancy and other health 
effects. In addition, while there is no effective pharmacological treatment for reversal of Arsenic 
toxicity, it is believed that diet rich in protein and micronutrient supplementation may protect 
against or minimize the impact of Arsenic-caused diseases in population heavily exposed to 
Arsenic. However, it is also not known to what extent diet, and micronutrients are related to 
methylation.  
Finally, clinical expressions of different forms of skin lesions, skin cancers, diabetes, other diseases, 
and malignant conditions define the interface between environmental health and health care 
organization. Thus, environmentally mediated diseases such as skin lesions, diseases of lung, and 
urinary bladder cancer in the Arsenic-exposed community change the patterns of access to care and 
challenge in the organization of preventive and palliative health care services. Therefore, studies in 
populations that are heavily exposed to environmental agents such as Arsenic provide opportunities 
to examine and modify explanatory and predictive models of health services organization, 
utilization, and access. 
In this dissertation, these four concepts have been examined using results from a nested case control 
study within a large cross-sectional survey in an Arsenic-exposed population in the North 24-
parganas district in India. The following questions are addressed in the subsequent chapters.  
1. What is the association between diet, micronutrients (nutritional factors) and arsenic-caused 
skin lesions? 
2. What is the association between methylation and arsenic-caused skin lesions 
3. What is the association between nutritional factors and arsenic methylation? 
4. How does these associations inform the process of health services research and health 
services utilization and access? 
Figure 1. Inter-relationship between nutritional factors, biomethylation, clinical outcomes, and 
interaction with health services utilization and access 
The inter-relationships between exposure to inorganic Arsenic, the metabolic transformation of 
inorgnaic arsenic through the process of methylation, the resulting clinical manifestation (skin 
lesions, skin cancers, diabetes, and cancers of other organs), diet and micronutrient supplementation 
are complex but important to understand for the mitigation of Arsenic toxicity related deaths and 
disability from a public health perspective. A complex set of social, and economic causes resulted in 
people's access to arsenic.  
The organization of the chapters for this dissertation are as follows. In this chapter the 
epidemiology of Arsenic toxicity in South Asia and its relationship to the clinical outcomes and 
helath care access and scope of the dissertation is briefly described. In addition, in this chapter, the 
mechanism of action of Arsenic (methylation), and discuss the evidence on the association of 
methylation and arsenic caused health effects. In chapter 2 will be discussed the methods of the 
survey, and the organization of the case control study design. In chapter 3 will be discussed the 
association between diet, micronutrients, and arsenic-caused skin lesions. Chapter 4 will discuss the 
association between methylation and arsenic-caused skin lesions. Chapter 5 will discuss the 
association between nutritional factors and arsenic methylation. Finally, in chapter 6 will be 
discussed the implications of these findings for health services research by examining the 
behavioural model of health services access and utilization of care and life course health 
development perspective of access and utilization of care. In particular, it will be examined how 
incorporation of environmental epidemiological data can address the “silo” based approaches that 
do not address the theoretical propositions of each model.  
Epidemiology of Arsenic toxicity 
[ Figure 1 goes here ] 
Figure 2: Distribution of exposure to inorganic Arsenic throughout the 
world 
Table 1. Prevalence of Arsenic-caused health effects 
[ Figure depicting a number of Arsenic-caused skin lesions] 
Figure 2: Arsenic caused skin lesions and other clinical manifestations 
Arsenic methylation and mechanism of action 
[ Figure depicting As --> As III --> MMA --> DMA ] 
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Figure 3: Steps of inorganic Arsenic methylation 
Statement of the problem and hypotheses 
What is the association between nutritional factors and Arsenic caused 
skin lesions? 
What is the association between methylation and Arsenic caused skin 
lesions? 
What is the association between nutritional factors and methylation of 
Arsenic? 
How do environmental epidemiology of Arsenic inform the process of 
health services research 
 
Figure 4: Interface between arsenic toxicity and health policy 
Organization of the subsequent chapters 
The methods and the study design for the survey and data analysis are outlined in Chapter 2. The 
data analysis, the results, and the discussion of the impact and health services implications for the 
association between nutritional factors and arsenic caused skin lesions are described in Chapter 3. 
In Chapter 4, the plans of data analysis, results, and implications of the results on the association 
between methylation and skin lesions are described. In Chapter 5, the plans of data analysis, results 
and implications of the findings with respect to health services research and access are outlined for 
the association between nutritional factors and methylation. Finally, in Chapter 6,  the relationships 
between health services research, access and utilization of care and environmental epidemiology are 
discussed.  
CHAPTER 2: POPULATION AND METHODS 
Abstract 
The purpose of this chapter is to provide the methodology of the cross sectional survey, and the 
organization of the case control study. This chapter provides an outline of selection of the 
population, organization of the cross sectional survey, the process of food frequency questionnaire 
based data collection, collection of urine samples and blood samples for further analysis at the 
University of Washington laboratory of Professor David Kallman, development of the nutritional 
data analysis software programme, and analysis of the data.  
Population under study 
Steps of the cross sectional survey 
Steps of the nutritional data analysis 
Steps of the blood nutritional factor analysis 
Steps of the urine analysis 
Statistical data analysis 
CHAPTER 3: NUTRITIONAL FACTORS AND SKIN LESIONS 
Abstract 
Exposure to inorganic arsenic is associated with development of characteristic skin lesions 
(alternating dark and light pigmentation, keratosis or thickening of skin, and other lesions). It is 
believed that diet and micronutrient supplementation can result in protective effects against 
development of arsenic caused skin lesions and other clinical manifestations of arsenic toxicity.  
A nested case control study was conducted within a larger population based cross sectional survey 
of 7394 individuals. Dietary information were obtained using a food frequency questionnaire; blood 
(plasma and serum) micronutrients were collected at the same time as conducting the diet survey 
and urine specimens were collected at the time of conducting the survey. The blood and urinary 
assays for micronutrients were conducted at the University of Washington laboratory. The clinical 
information on the participants were obtained by trained physicians. The data were analyzed using a 
matched case control study and logistic regression models.  
Arsenic toxicity in West Bengal and its impact on Health Services  
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Abstract 
Worldwide, millions of people who are exposed to inorganic arsenic present with skin lesions, and 
cancers of skin, urinary bladder, liver, and lungs, among other diseases. In South Asia, in the states 
of West Bengal of India and the adjoining districts of Bangladesh alone, about 130 million people 
are exposed to inorganic arsenic exceeding 50 micrograms per liter in their drinking water, about 5 
times the maximum contaminant level set by the United States Environmental Protection Agency 
and the WHO. The emergent burden of diseases will likely to impact patterns of healthcare 
utilizations for dermatological and oncological services for these countries. Epidemiological studies 
suggest that diet and select micronutrients have limited roles in the pathogenesis of arsenic 
poisoning, and that in vivo methylation may enhance toxicity or increase susceptibility to arsenic 
poisoning. In this dissertation, the evidence from available studies on the inter-relationships 
between diet, methylation and arsenic-caused skin lesions will be examined in combination with 
primary studies conducted in an arsenic-exposed population in West Bengal, India. Based on the 
findings of these studies, this dissertation will examine an existing model of health care utilization 
profiles for people living in high exposure areas. It is hypothesized that in addition to health care 
seeking behavior, health care utilization patterns are also functions of physical environment. Finally, 
this dissertation will argue for an interdisciplinary approach to better comprehend patterns of 
healthcare utilizations, breaking away from the current "silo" approach of non-integrating 
disciplinary work in explaining health care utilization profiles.  
1  Overall Problem 
Worldwide, environmental exposure to inorganic arsenic accounts for considerable morbidity and 
mortality [2]. Continuous exposure to inorganic arsenic over 5 to 10 years eventually leads to skin 
discolorations and thickened lesions (hyperpigmenation and keratosis), peripheral neuropathies, 
chronic respiratory diseaes (chronic bronchitis and bronchiectasis), diabetes mellitus, and cancers of 
skin, urinary bladder, liver, renal failure and lungs [20]. The International Agency for Research on 
Cancer has stated that there exists sufficient evidence in humans that arsenic in drinking water 
causes cancers of lung, urinary bladder, and skin [1].  
In developing countries, drinking water is the most common route of exposure to arsenic; others 
include food, and air. In 2001, the United States Environmental Protection Agency revised the 
maximum contaminant level of arsenic in groundwater and recommended a maximum contaminant 
level of exposure to inorganic arsenic at 10 micrograms per liter, based on the risk estimate of 1 in 
300 for arsenic levels at 10 micrograms per liter [14]. At exposure levels of 50 mcg/L – a maximum 
contaminant level still adopted by India and Bangladesh are 5 times the current recommended 
maximum contaminant level. Millions of people worldwide are exposed to high concentrations of 
arsenic. In South Asia alone, between Bangladesh and the adjoining West Bengal state of India, 
about 130 million people are exposed to inorganic arsenic through their groundwater supply 
exceeding 50 micrograms/L, and are at risk of developing long term consequences of arsenic 
exposure [16, 11]. Large scale exposure to inorganic arsenic in drinking water began in the 1960s in 
South Asia, when shallow alluvial aquifers of the Bengal delta were tapped to obtain groundwater. 
This was primarily done under guidance from International Agencies in order to reduce the burdens 
of diarrheal diseases brought about by consumption of coliform bacteria-contaminated surface 
water from lakes and tanks and to supply water for irrigation. In the sixties, in Bangladesh alone, 
the infant mortality rate from diarrheal diseases were about 14 per 100, making it to be the leading 
killer disease. Installation of tubewells resulted in about 44% reduction in infant mortality from 
diarrheal diseases in Bangladesh. Additionally, installation of tubewells also made light of the 
workload of the womenfolk to fetch water from long distances and provided an ownership of 
having their source of drinking water in their own homes [4]. These twin effects sustained the 
acceptability of tubewells as a source of drinking water in a large number of households across 
South Asia. Arsenic-caused skin lesions emerged as public health problem in South Asia in the 
1980s. Since 1983, when the first cluster of 16 cases of arsenic-caused skin lesions were detected at 
Calcutta’s School of Tropical Medicine by Professor Kshitish Chandra Saha, thousands of cases of 
arsenic-caused skin lesions and other arsenic-caused diseases have been diagnosed in West Bengal 
and Bangladesh. The large number of patients with arsenic-caused health effects as a result of 
exposure to high concentrations of arsenic in their drinking water has been compared to 
environmental disasters in Bhopal and Ukraine and described as the worst environmental disaster in 
the twentieth century  [15, 18]. 
Inorganic arsenic remains in groundwater sources largely in As(V). Once it gains entry to human 
body through drinking water, inorganic arsenic undergoes series of biotransformations in liver 
sequential stages of alternative reduction and enzyme mediated biomethylation. These metabolic 
stages result in arsenic interacting with body tissues and altered methylation patterns of DNA and 
cellular transport mechanisms leading to its pathogenesis. Following entry to human body, As(V) is 
first reduced to As(III) and then sequentially methylated to monomethyl arsonous and arsonic acids 
(MMA(III) and MMA(III)) and dimethyl arsinic acids (DMA(III) and DMA(III)). It was earlier 
believed that methylation was a detoxification process; following isolation of MMA(III), studies 
with human tissues and animal experiments suggest that MMA(III) can be more toxic compared to 
Arsenic (III) and As(V), and consequently, methylation may not be entirely detoxifying, and in 
fact,can be harmful. Methylation of arsenic is incomplete and ingested inorganic arsenic is excreted 
as 10-20% as inorganic arsenic, 10-15% as monomethyl arsenic (MMA), and 60-75% as dimethyl 
arsenic (DMA)  [10] 
Data from the dose-response studies conducted in Taiwan in 1989 and 1992 on the association 
between arsenic exposure and arsenic-caused skin cancers suggested a strong dose response 
effect [20]. Engel and colleagues suggested that low intakes of micronutrients in Taiwan population 
may have made them more susceptible to arsenic-caused skin cancers  [12]. Results from a matched 
case control studies among Atacameno people in Chile suggested that despite good nutritional status 
of these population, the prevalence of arsenic caused skin lesions in this population as a result of 
exposure to arsenic laced drinking water were comparable to that in comparable regions of the 
world [17]. A large nested case control study within a larger cross sectional survey conducted in an 
arsenic-endemic population in West Bengal, India reported that people who were in lowest quintiles 
of dietary intakes of protein were likely to be susceptible to arsenic-caused skin lesions, and another 
study on the blood levels of micronutrients and arsenic-caused skin lesions failed to find 
associations between selenium methionine, and beta-carotenes and arsenic-caused skin lesions [12, 
6]. No data is available on the impact of diet, together with micronutrients on arsenic-caused skin 
lesions.  
Environmental epidemiological studies constitute the evidence base for key health care policies 
aimed at mitigation of the arsenic toxicity in arsenic-endemic populations. For instance, animal- and 
human tissue-based experiments suggest that inorganic arsenic and selenium antagonize each other, 
and that selenium deficiency may increase susceptibility to arsenic induced cancers of liver [7, 9, 
19]. While the "perceived" efficacy of selenium supplementation on theoretical and biological 
grounds might be justified to initiate an expensive public health program of population based 
selenium supplementation in Bangladesh at great expense, the outcome of at least one placebo 
controlled randomized trial of selenium supplementation had low efficiency. In one placebo 
controlled double blind randomized controlled trial of selenium supplementation, either alone or in 
combination with Vitamin E supplementation, the investigators found that selenium 
supplementation had modest improvement in arsenic-causes skin lesions that were not statistically 
significant [Error: Reference source not found]. it failed to mitigate the arsenic toxicity profiles of 
the Bangladeshi population to whom it was targeted. To understand the gap between efficacy and 
efficiency of mitigation programs driven by solely environmental epidemiological findings and 
limited understanding of biology of arsenic toxicity bereft of the context in which toxicity and the 
health care delivery response occurs deserves a fuller explanation. 
Interaction between emergence of environmental health problems and health care utilization and 
access to care is a dynamic process. In the context of arsenic toxicity, groundwater residing at 10-80 
meter depth was tapped in 1960s, in order to find a solution to increased infant mortality and ill 
health related to drinking surface water that was contaminated with coliform bacteria. Before 
initiation of tubewells in Bangladesh, the work of fetching water from long distances was an 
additional task for the womenfolk of the households, and use of tubewells soon became widespread 
as people invested their resources in the technology to bore tubewells closer to their homes, often in 
their backyards. The net result was now there was an ownership of drinking water and this was 
prized [5]. However, at the time of sinking these tubewells, the water was not tested for the 
presence of inorganic arsenic in them. In 1983, the first cases of arsenic toxicity emerged in West 
Bengal, India, when dermatologists started seeing more cases of palmar and plantar 
hyperkeratoses [18]. Thus, a sudden increment in the utilization of dermatological services was 
associated with further testing of their drinking water sources which revealed high concentrations of 
arsenic in the groundwater. At the estimated prevalence of 20 percent, and an exposed population of 
42 million people in West Bengal who are exposed to high arsenic in drinking water, over the next 
5-10 years, about 8 million people would be likely to use not only dermatological services but also 
be additional burdens to urological services (because of the association between arsenic and urinary 
bladder cancer), respiratory care (association between arsenic and chronic respiratory diseases, lung 
cancer, and bronchiectasis), and liver diseases.  
Traditional explanatory models of health services research and health care utilization focus on 
behavioral constructs of health care utlization patterns. Ronald Andersen’s Behavioral Model, 
developed initially in the 1960s and later expanded with 4 iterations, has been widely used for 
explaining and predicting health care utlization pattern for families and individuals. Briefly, in this 
model, health care utilization has been explained by three inter-related factors: predisposing factors, 
for instance, a person’s demographic and socioeconomic factors which also include physical 
environment, enabling factors (including social situations, financial status, existing health policies) 
and need factors (evaluated need factors that which is determined by the physicians or realized need 
where the patient actually accesses the healthcare system and complies). Study by Aday and 
colleagues suggest that provider-related and contextual variables explain the utilization patterns of 
heathcare by about 20 percent. It may be argued that external physical environmental factors can 
also explain variations in healthcare utilization patterns, as can be shown by the case with arsenic 
toxicity in South Asia [3, 13].  
The purpose of this dissertation is to describe the inter-relationship among diet, micronutrients, 
arsenic methylation, and arsenic-caused skin lesions in an arsenic-exposed population in the state of 
West Bengal in India, and bridge the translational gap between environmental epidemiological 
studies and the traditional models of health services research that focus on behavioral components 
of health care utilization patterns, putting less emphasis on the nascent variables of environmental 
health related agent provocateurs that impact how people access and utilize existing health care 
delivery systems. In building this argument, we have laid out the chapters as follows. This first 
chapter will discuss a brief history of the arsenic toxicity in South Asia, followed by description of 
the health impacts of arsenic exposure. In describing the health impacts of arsenic exposure, we 
shall limit ourselves to the arsenic-caused skin lesions, since these develop after 5-10 years of 
exposure to inorganic arsenic and are specific to arsenic toxicity. We shall conclude this first 
chapter with a discussion on the interface with health services research issues, specifically how 
arsenic toxicity, as a talking point, builds on the health behavioral model proposed by Andersen and 
how potentially, the scope of the Andersen model can be expanded with data from enviromental 
epidemiologic studies. Chapter 2 will describe the association between diet, micronutrients, and 
arsenic-caused skin lesions. Chapter 3 will describe the association between methylation patterns 
and arsenic-caused skin lesions. Chapter 4 will describe the association between diet, 
micronutrients, and patterns of arsenic methylation. Finally, chapter 5 will begin with a 
restatementn of the overall goal, summarize the study findings, discuss the limitations of these 
studies in applying them to the health services research framework, and finally implications of these 
studies for formulating health policies and future directions that research might take to integrate 
environmental epidemiologic studies and health services research paradigms. 
2  History of Arsenic Toxicity in South Asia 
In the nineteen sixties, demand for water for drinking and irrigation increased in India and 
Bangladesh because of increased population and agricultural activities. At that time, surface water 
from lakes, ponds and rivers were the only sources of water for drinking and agricultural purposes. 
Surface water had high coliform bacterial load and consumption of surface water resulted in high 
prevalence of diarrheal diseases, particularly in young children, with prevalence was about 140 per 
1000 population [5]. To address the need of increased demand for water and increasing burden of 
diarrheal diseases among children, UNICEF (United Nations International Children’s Emergency 
Fund) and other agencies advised the Government of India to sink of tubewells at depths ranging 
between 20 and 60 meters in order to tap groundwater. During that time, water was not tested for 
the presence of inorganic arsenic. Following sinking of tubewells, mortality rates due to diarrhea 
fell in BD by 44% (UN Report, 1999). At the time of sinking tubewells, presence of arsenic in 
groundwater was not tested. Presence of arsenic in groundwater went largely undetected for a long 
time and therefore no mitigation efforts were instituted because inorganic arsenic in groundwater 
does not impart any color or smell to the water consumed and therefore invisible. In 1983, Dr. 
Kshitish Chandra Saha, a dermatologist in Calcutta’s School of Tropical Medicine and Hygiene first 
reported a case series of patients he had examined for the presence of arsenic-caused skin lesions. 
The first cases of arsenic-caused skin diseases were reported in 16 individuals from one village in 
1983. In 1986, following a newspaper report about a patient from the villages in South 24-Parganas 
who attended the clinic of Professor KC Saha, the Government of West Bengal initiated 
investigations into the extent of arsenic toxicity in West Bengal [16].  
By 1987, 6 districts in West Bengal was declared to contain arsenic in groundwater and xx 
districts in Bangladesh was found to contain arsenic in groundwater above the levels of 50 
micrograms/ L. In 1995-1996, Dr DN Guha Mazumder initiated the first large scale cross sectional 
survey in West Bengal to study the prevalence of Arsenic toxicity in West Bengal. In 2001, the 
United States Environmental Protection Agency revised their recommendations for the maximum 
contaminant level for arsenic from 50 micrograms/L to 10 micrograms/L. However, Government of 
India and Bangladesh maintained the maximum contaminant levels at 50 micrograms/L. This was 
justified in view of the large number of people who were exposed, the costs to be invested in 
technology to reduce the well water concentration to 10 micrograms/L and to maintain the impact 
of the mitigation efforts like dug well programs [8].  
3  Descriptive Epidemiology 
3.1  Prevalence of arsenic caused skin lesions 
In the West Bengal state of India, about 42.7 million people spread across 39,000 square kilometer 
area in 9 districts were exposed to arsenic in groundwater exceeding 50 micrograms per liter. with a 
total population of 68 million in West Bengal, this indicates that about 63% of the total populaiton 
in West Bengal is exposed to arsenic in drinking water exceeding 50 micrograms/L and therefore at 
risk. In Bangladesh, about 79.9 million people in 42 districts, spread across 150,000 square 
kilometer are exposed to arsenic levels exceeding 50 micrograms per liter. Bangladesh has 64 
districts in all, with about 120 million population. Thus, in Bangladesh, about 66.7% of the 
population of Bangladesh are exposed to arsenic in groundwater exceeding 50 micrograms per liter, 
exposing them to arsenic caused skin lesions and other clinical effects of arsenic exposure. In 
Bangladesh, a total of 11 million tubewells are known to have arsenic concentrations of 50 
micrograms/liter or higher. About 97% of the wells in the South and Southwestern parts of 
Bangladesh are known to contain arsenic exceeding 50 mcg/L.  
Nine cross-sectional surveys in West Bengal and Bangladesh were identified that aimed to study 
the prevalence of arsenic-caused skin lesions among the population in different villages or districts 
of the two regions. Data were abstracted from these surveys and prevalence of arsenic caused skin 
lesions were calculated for the entire population they surveyed. Based on their study estimates, the 
ranges of arsenic-caused skin lesions were found to vary between 3 per 1000 for a large cross 
sectional survey of 166,934 individuals in the xx district of Bangladesh to 290 per 1000 population 
in the yy district of Bangladesh. For West Bengal, the prevalence ranged between 46.9 per 1000 for 
hyperpigmentation (combined for men and women for all ages), to 190.4 per 1000. In general, 
prevalence were found to be high for those studies that had non-random sampling (based on 
volunteer based reporting). The estimated median prevalence of arsenic-caused skin lesions among 
arsenic-endemic areas of West Bengal and Bangladesh would be about 68.9 per 1000 population.  
Increased age was associated with increased risk of arsenic-caused skin lesions, and men had 
higher rates of arsenic-caused skin lesions than women. Association between socioeconomic status 
and arsenic-caused skin lesions were inconclusive. In one large population based cross sectional 
survey in Bangladesh, people who had higher socioeconomic status (measured by high total family 
income) had higher risk of arsenic caused skin cancers in multivariat models. The authors 
commented that this was because of high private tubewell ownership and consequently a function 
of high intake of arsenic-laced drinking water.  
Low dietary intakes of specific dietary items and specific micronutrients are associated with 
increased risk of arsenic-caused skin lesions in West Bengal and Bangladesh. However, the 
combined effects of low dietary intakes of specific dietary items and micronutrients taken together 
on arsenic-caused skin lesions is unknown. This problem has been addressed in this dissertation. 
Increased methylation is associated with arsenic-caused health effects, including arsenic-caused 
skin cancers, and cancers of urinary bladder. One cross-sectional survey in Taiwan noted that 
increased methylation and output of MMA in urine was associated with increased risk of arsenic-
caused skin pigmentation.  
4  Interface with Health services research 
Environmental arsenic poisoning accounts for considerable morbidity and mortality worldwide in 
general, and in particular, for Bangladesh and the West Bengal state of India. As we identified 
before, about 63% of the total population of West Bengal (N = 42.7 million) and 67% of the total 
population of Bangladesh (N = 79.9 million) are exposed to arsenic in their groundwater exceeding 
50 micrograms per liter. Assuming an average prevalence of 6.9 % individuals exposed to arsenic 
levels exceeding 50 micrograms per liter would develop arsenic-caused skin lesions, it is estimated 
that in West Bengal, about 2.95 million people would develop skin lesions in 5 –10 years following 
exposure. Similarly, for Bangladesh, an estimated 5 million people would develop arsenic-caused 
skin lesions. In addition, assuming 1 in 300 individuals would develop skin cancers or internal 
cancers resulting from exposure to arsenic in groundwater, an estimated 142,333 people would 
develop cancers resulting from arsenic exposure in West Bengal and 266.333 people in Bangladesh 
will develop arsenic-caused cancers of skin, urinar bladder, and lungs over the next 20 years. These 
figures suggest that utilization for oncological and dermatological services are likely to be 
considerably higher in areas of high arsenic-endemicity compared to residents in geographical areas 
where arsenic exposure is not a major environmental health problem. 
Traditionally, health services utilization have focused on health behavior pertinent to utilization 
of health services. A popular theory of health services utilization was proposed by Ronald Andersen 
in 1960s and was subsequently modified by Andersen, Aday and others through four iterations.  
Briefly, Andersen reviewed the history and emergence of a model explaining health care 
utilization in four phases. The first iteration was his original theory in 1960s where he posited that 
health care utilization profiles for families could be explained by invoking specific predisposing, 
enabling and need based factors. This was modified in the 70s and eighties where additional 
dimensions of health status and health outcomes were added to the model. In the third iteration of 
the model, that was prevalent in the last decade of the twentieth century the focus was on health 
status and health outcomes as well as on personal health behavior. He added a new category to the 
access variables in addition to the original groupings in terms of potential accesss that the patients 
had resources available and the society provided them opportunities to access the health care 
services, realized access to what extent the services were utilized, the equitability of accesses 
whether demographic and need variables determined the access to healthcare issues when that 
would be termed as equitable access and when variables such as resources and health beliefs 
wereexplanatory variables for healthcare access, then that would be defined as inequitable access. 
In the third iteration, Andersen added concepts of effective and efficient accesses. Effective access 
was defined s access that improved health status or satisfaction of the clients who accessed 
healthcare in this phase. Efficient access was whether, in comparison to the resources used or 
utilized, the health status or satisfaction with healthcare increased substantially. Andersen argued 
about the more mutable a factor was, the more it could contribute to explain the variability 
associated with health care utilization patterns. For instance, demograhic and social factors were not 
mutable at all, while health policy related variables that included clinical guidelines etc that tended 
to vary with improved research and greater access to information. In the fourth iteration of his 
model, he included feedback loops to the model where he stated that outcomes would influence 
thedeterminants of the utilization pattern and consumer satisfaction and other system variables. 
Notable in this descriptions of health care utilization models were the absence of the impact of 
physical environment. Being included as immutable predisposing factors, the importance of 
physican environmental variables were perceived less important in comparison to other factors. 
Andersen’s model was criticized and modified by Phillips and colleagues where they stated that 
while Andersen’s model laid emphasis on the individual behavior for explaining health care 
utilization, it did not sufficiently discussed issues related to either environmental or provider-related 
variables. By environmental, Phillips indicated variables that related to health care delivery system 
characteristics like policy, resources, etc, (b) external environmental variables mainly relating to 
financial and economic and social environment, rather than physical environment, and community 
level enabling factors. 
Experience in South Asia on the emerging arsenic toxicity and the potential impact of arsenic 
toxicity on health care utilization patterns suggest a review of the existing models of health care 
utilization and the need for factoring in external environmental variables as important determinants 
of healthcare utilization patterns to explain the variability in the healthcare utilizations in specific 
areas where environmental health related issues are important contributors to illness profiles in 
these areas.  
This dissertation will provide an evidence base for health policy aimed to reduce the burden of 
diseases due to arsenic. In particular, dietary and micronutrinet supplementation has been a 
mainstay of the mitigation of arsenic toxicity. However, there has not been evidence base to justify 
if supplementation with Folate or selenium can alter the course of arsenic toxicity. Before expensive 
arsenic mitigation programs are undertaken to address the issue of arsenic toxicity, these issues need 
to be discussed. In elucidating the associations between diet, micronutrients and arsenic-caused skin 
lesions, and subsequently associations between methylation and arsenic-caused skin lesions and 
associations between diet, micronutrients and arsenic methylation, this dissertation aims to provide 
an evidence base from the perspective of environmental epidemiology. In summary, weaving 
evidence from environmental epidemiological studies, and translating the research in the language 
of health services research, this dissertation aims to create an interface between environmental 
epidemiology and health services research.  
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Table 3. Distribution of arsenic toxicities in West Bengal and Bangladesh (Ref: Chowdhury et al) 
Year or Range of years Event Impact
1960s Increased prevalence of 
diarrheal diseases, decision to 
install tubewells at depths of 
20-60 m
Arsenic in drinking water was 
not measured at that time
1982 Diagnosis of arsenicosis 
patients by Prof Kshitish 
Chandra Saha at School of 
Tropical Medicine, 16 patients 
in a cluster of villages in South 
24 Parganas district of West 
Bengal
Incident cases of Arsenicosis, 
emergent problem
1986 West Bengal Government 
forms a committee to 
investigate the arsenicosis 
problem
Investigations into the topic of 
arsenicosis in West Bengal
1995 First cases of arsenic toxicity 
determined in Bangladesh
1995-1996 Cross sectional survey of 7683 
individuals initiated in West 
Bengal
2001 United States EPA and the 
WHO revised maximum 
contaminant level of arsenic 
from 50 microgram/L to 10 
micrograms/L
India and Bangladesh still 
acknowledged the 50 
micrograms/L maximum 
contaminant level margins
Parameter Bangladesh West Bengal, India
Total Area 148393 89192.4
Total Population(million) 120 68
Number of districts 64 18
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Table 4. Prevalence estimates for Arsenic caused skin lesions from studies conducted in India (West 




Area of the affected districts 92106 38865
Population of affected districts 79.9 42.7
Districts that have people with arsenical skin lesions 25 7
Author,year population size skin lesions prevalence notes
Rahman, 2006 Bangladesh 166934 504 3.02
cross-sectional survey of all 
eligible persons in a particular 
geographical area
McDonald, 2006 Bangladesh 13705 176 12.84
random sampling among 




India 7683 361 46.9
Combined result for 
hyperpigmentation
Ahsan, 2006 Bangladesh 14828 714 48.15




Bengal,India 33000 2274 68.91





India 29035 4420 152.23
cross sectional survey with 
voluntary recruitment of 




India 25274 4813 190.43
cross-sectional survey based 
on volunteer response
Chowdhury, 2000 Bangladesh 11180 2736 244.72
cross sectional survey with 
voluntary recruitment of 
people with skin lesions
Tondel, 1999 Bangladesh 1481 430 290.34
cross sectional survey with 
nonsystematic sampling of 
wells and individuals above 
30 years of age
Table 2: Demographic variables, socioeconomic status, and outcome 
variables 
Table 3: Dietary variables and micronutrients mean (sd) 
Table 4: Average nutritional factors between cases and controls 
Table 5: Adjusted Ors for nutritional factors between cases and controls 
Discussion 
Association between dietary intakes, serum levels of micronutrients and arsenic-caused skin 
lesions: results from a case control study in West Bengal, India 
Abstract 
Background. -- Skin lesions are manifestations of arsenic toxicity. Earlier studies report that people 
with low intakes of specific dietary elements, or those with low serum levels of anti-oxidants are 
susceptible to arsenic-caused skin lesions. This is the first study to report combined effects of diet 
and micronutrients on susceptibility to arsenic-caused skin lesions.  
Methods. -- We conducted a case-control study in an arsenic-exposed population in West Bengal, 
India. We selected age- and gender-matched cases and controls from a cross-sectional survey in 
West Bengal from individuals exposed to inorganic arsenic in their groundwater (upto 500 ug/L). 
We calculated their dietary intakes, and measured micronutrients from their blood samples. We 
regressed case-control status on quintiles of dietary intakes and serum micronutrients. In 
multivariate models, we adjusted for the effects of demographic, socioeconomic, arsenic-exposure, 
other dietary variables, and serum micronutrients as covariates. 
Results. -- Cases and controls had similar housing (p = 0.37) and educational status (p = 0.27). 
Cases had lower levels of urinary  inorganic arsenic excretion (p = 0.01), and lower dietary intakes 
of Vitamin A, Iron, Fiber, Animal Fat, Calcium, and lower serum Beta-cryptoxanthine. Compared 
with individuals in the highest quintiles, those in the lowest were about 3.5 times susceptible to skin 
lesions for dietary Vitamin A (OR=3.43;95% CI:1.19-9.90), 2.7 times for dietary Iron 
(OR=2.68;95% CI:1.34-5.35), 2.5 times for dietary fiber (OR=2.45; 95% CI:1.25- 4.81), and about 
twice for Animal Fat (OR = 2.1, 95% CI: 1.11 - 3.97), and beta- cryptoxanthine (OR = 2.07, 95% 
CI = 1.05 - 4.05). In multivariate models, low dietary intakes of Vitamin A, and low levels of serum 
beta cryptoxanthine were associated with increased susceptibility to skin lesions. 
Discussion. -- Low Vitamin A intake and low levels of serum antioxidants are consistently 
associated with arsenic-caused skin lesions. 
Conclusion. -- This study provides limited evidence that low dietary intakes of Vitamin A and low 
serum micronutrients may increase susceptibility to arsenic-caused skin lesions in exposed 
population.  
Background 
More than 80 million people in the West Bengal state of India and its adjoining areas in Bangladesh 
in teh Ganges river delta area are exposed to inorganic arsenic in the groundwater exceeding 50 
microgram/L (?ref). Skin lesions are protean manifestations in response to long term exposure to 
such high concentration of inorganic arsenic. These include alternate dark and light skin 
pigmentation on the trunk (melanosis) thickened dark skin pigmentation (keratosis), and nodular 
deformities (Guha Mazumder). Presence of skin pigmentation with evidence of exposure to high 
concentrations of inorganic arsenic (exceeding 50 ug/L) is hallmark of arsenic toxicity (??). Skin 
manifestations are initial manifestation of arsenic toxicity and in addition to skin pigmentation, 
prolonged arsenic exposure also results in skin cancer (Bowen's disease), and cancers of urinary 
bladder, lung, and liver (refs??). Arsenic exposure is also associated with non-malignant diseases, 
including diabetes, hypertension, chronic obstructive pulmonary diseases, and bronchiectasis, 
among others (refs??).  
Diet and micronutrients play important roles in susceptibility to arsenic-caused skin lesions. In the 
1960s, when studies from Southwestern Taiwan suggested that high exposure to inorganic arsenic 
was associated with increased risk of skin cancers, it was argued that susceptibility to arsenic 
toxicity among the Taiwanese population could be attributable to the dietary patterns of the 
Taiwanese that was rich in Tapioca and carbohydrates and low in protein and therefore made them 
more susceptible to arsenic-caused skin cancers, while relatively higher dietary protein intake of the 
US population might result in lower susceptibility for the US or a diet-for-diet comparable 
population. On the other hand, cross sectional studies among the Atacameno people in Chile, who 
are exposed to high concentrations of inorganic arsenic through natural water, but also have good 
nutritional status through generations, suggest that despite generations of high dietary protein intake 
and good nutrtional status, prevalence of arsenic caused skin lesions in this population was 
comparable to those found in other geographical areas in the world which had comparable arsenic 
exposure (Smith). Nevertheless, results from population based cross-sectional surveys and case 
control studies from Southwestern Taiwan, Bangladesh and India continue to provide evidence that 
dietary deficiencies in protein, xxx, aaa, or low serum levles of beta carotene, methionine and xxx 
result in higher susceptibility to arsenic-caused skin lesions in these populations (refs??).  
The purpose of this paper is to present results of our case control study on the combined effects of 
diet and micronutrients on arsenic caused skin lesions. This is the first study that considered the 
effects of dietary variables, together with serum micronutrients.  
Methods 
We conducted a population based case control study nested within a larger cross-sectional survey. 
The ascertainment of cases and controls, and the methods of assessment of dietary variables, and 
serum micronutrients are described below. 
Study participants 
We conducted a cross-sectional investigation of 180 cases who had skin lesions and 192 persons 
who did not have skin lesions, in the North 24 Parganas district, of the state of West Bengal in 
India, between 1998 and 2000.  
Participants had been selected for a previously completed case-control study of arsenic-caused 
skin lesions [11]. The study base for selection of cases and controls involved 7683 individuals who 
participated in a 1995-1996 population based cross-sectional survey of the South 24 Parganas, a 
rural district located south of Calcutta. The survey identified 415 individuals with signs of arsenic-
induced skin lesions [10]. Water samples were collected from the primary current drinking-water 
source of each participant. Because of our interest in examining effects at low doses, we based the 
case-control study on survey participants whose primary drinking water sources contained less than 
500 micrograms/liter of inorganic arsenic (N = 4815, 2160 females and 2025 males). The study 
involved 180 cases and 192 controls. Cases were individuals who had a positive skin lesion 
classification, with either hyperpigmentation (mottled dark brown pigmentation bilaterally 
distributed on the trunk) or keratoses (diffuse thickening of palms or soles, with or without nodules) 
at the time of survey. Controls were randomly selected from the study base, and matched to the 
cases by gender and age within 4 years. The study protocol was approved by the Institutional 
Review Boards of the Institute of Post Graduate Medical Education and Research, Calcutta and the 
University of California, Berkeley. Informed consent was obtained from all participants.  
The current investigation we report here uses cross-sectional data from the cases and controls 
including dietary assessment, measurement of blood micronutrients, and measurement of 
methylated arsenic species in urine samples. The controls were selected to be representative of the 
source population as described above. Cases with skin lesions are included in the present analysis to 
increase the numbers of participants. As explained below, we checked for distortion of associations 
between nutritional factors and arsenic methylation patterns due to the inclusion of both cases and 
controls. 
Assessment of dietary intake and blood micronutrients  
For each participant, we meaured weight and height and calculated the body mass index (BMI). We 
ascertained food intake for each participant with a detailed questionnaire based primarily on 24-
hour recall. We have previously presented the methods used for dietary assessment [12]. In brief, 
the senior woman, who in this population directs preparing food for the family, was interviewed. 
The senior woman, was often the mother in the family or the eldest daughter-in-law, was questioned 
about each meal from the previous day’s lunch through to the breakfast on the day of the interview. 
The volume of each cooked food was assessed by questioning the senior woman using standard 
cups and plates. Standard sized spoons were used to assess the intake of sugar and oil. We asked 
about weekly consumptions of meat, fish, eggs, milk, and fruit because these items were not 
consumed on a daily basis. The 1-week intake of these food items was then divided by 7 to compute 
the average intake per day. We calculated total 24 hour intake of each nutrient using a spreadsheet 
program based on food composition tables.  
Field physicians interviewed participants using a structured questionnaire, conducted a general 
examination, and obtained blood samples from each participant when they were visited in their 
homes. We have previously presented detailed information concerning storage and analysis of blood 
samples [6]. In brief, nonfasting blood samples were collected and stored in an ice chest in the field. 
Aliquots were prepared within 24 hours, frozen at -20 deg C in India, later transported to the United 
States on dry ice where they were stored at -70 deg C until laboratory analysis. Pacific Biometrics 
(Seattle, WA) conducted most serum and plasma analyses for the micronutrients and biochemical 
indicators, or in some instances arranged for them to be done at a different laboratory. Plasma 
measurements included Homocysteine, glutathione, cysteine, methionine, vitamin B6, retinol 
(Vitamin A), alpha-tocopherol (Vitamin E), alpha-carotene, beta-carotene, lycopene, lutein-
zeaxanthin, and beta-cryptodextrin.  
Serum measurements included glucose, cholesterol, vitamin B12, folate, transthyretin, and 
selenium. 
Ascertainment of cases and controls 
Ascertainment of cases and controls. – The survey team members questioned each participant 
about sources of drinking water, current diet, water intake, symptoms, height and weight. Each 
participant received a general medical examination, and survey team physicians carefully inspected 
for arsenic skin lesions.  
We used the following criteria for classifying keratoses and hyperpigmentation as arsenic-
caused. Keratoses had to involve bilateral diffuse thickening of palms and/or soles with or without 
nodules of various shapes and sizes. Hyperpigmentation were areas of mottled dark brown 
pigmentation bilaterally distributed on the trunk. Hyperpigmentation was frequently also present on 
the limbs, and sometimes alongside spots of depigmentation, but these characteristics were not 
regarded as essential for diagnosis. One of two field physicians in the survey team examined all 
patients in a well-lit area outdoors, under natural light.These physicians had about 10 years of 
experience each in diagnosing arsenic-caused skin lesions in West Bengal, including examining 
patients regularly in the Arsenic Clinic in the hospital linked with the Postgraduate Medical Institute 
in Kolkata. The physicians documented visible or palpable dermal lesions noting the location, 
appearance, and whether the patterns were characteristic of arsenic-induced skin toxicity. Part-way 
through the project, interviewers photographed the most highly affected skin lesions. The Four 
project physicians later reviewed the slides. After joint review and discussions, the physicians 
classified the skin lesions (by consensus) as "definite", "probable", "possible", or "not related" to 
arsenic. Dermal changes "definite", or "probable" induced by arsenic were classified as current skin 
lesions. Participants, for whom slides were not available, were classified as having skin lesions if 
the physician interviewer recorded on the questionnaire that the dermal changes were of a type 
related to arsenic (Haque, 2003). 
Field workers knew whether a village where they were working was located in the high or low 
exposure area. However, they had no information on the tubewell arsenic concentration at the time 
of working in the area. Physicians examined the participants only after they were first interviewed 
by the field workers. While the water samples were obtained on the same day as the interview and 
medical examinations, but the results of the analyses for arsenic were not known until months later. 
Thus the physical examinations for skin lesions were conducted blind as to water arsenic 
concentrations which showed a wide variability, with contaminated wells scattered irregularly 
throughout the study region.  
We selected controls from survey participants who did not have skin keratoses or 
hyperpigmentation when seen during the 1995–1996 survey, and whose main tube well-water 
source, like the cases contained < 500 micrograms/liter of arsenic. For each case, we selected one 
control matched on age (plus or minus 5 years) and sex randomly from all eligible non-cases. We 
selected replacement controls for controls who had died, could not be located or did not wish to 
participate. 
Statistical data analysis 
This was an exploratory data analysis where the aim was to identify the set of dietary and serum 
micronutrients that were associated with skin lesion status.  For every dietary variable, we adjusted 
for the calorie intakes of the dietary variables by dividing them with their calorie intake for each 
individual (Willet). For dietary variables and serum micronutrients, all non-detectable values were 
considered as missing values and were removed from the analysis. We also converted earch dietary 
and micronutrient variable into its corresponding quintile form based on the values for controls (ie 
converted a continous variable into a categorical variable with five levels based on the lowest value, 
the 20th, 40th, 60th, 80th quintiles, and maximum values for those of the control population as 
break points to denote the cut-off values for levels). This was done for three reasons. First, doing so 
would make odds ratios comparable between the variables. Second, if outliers were included in the 
analyses, they would be incorporated within the lowest or the hightest quintiles and would not need 
to be separately treated or removed from the analysis, thus maintaining optimum power. Third, 
adjust for the effects of potential collinearity among individual variables when they were included 
in multivariate models.  
We compared levels of educational attainment, and types of housing between cases and controls 
using chisquare tests of trend for contingency tables. For continuous variables, we compared 
median values of dietary variables, serum micronutrients, and indicators of methylation (urinary 
percentages of inorganic arsenic, monomethyl arsonous acid and dimethyl arsinic acids) between 
cases and controls.  To test whether the differences in the median for these variables between cases 
and controls could be due to chance, we used Wilcoxon nonparametric tests of comparison and its 
associated p-value at 0.05 cut-off.  
We used simple unconditional logistic regression with age and gender as co-variates for identifying 
the initial set of dietary variables and serum micronutrients that would be included in the 
subsequent mulivariate logistic regression models. Here, we regressed the outcome variable -- the 
case-control status -- on each dietary and serum micronutrient variable in turn, and compared the 
exponentialized standardized beta of the generalized linear model (the Odds Ratio) along with the 
95% Confidence Interval bands (the lower and the upper limits of the 95% confidence interval of 
each dietary variable and serum micronutrient). After the regression was run through the entire list 
of dietary and micronutrient variables, they were rank ordered in descending absolute values of 
their beta coefficients.  
We selected further variables for multivariate models from the list based on their beta coefficient 
(and therefore Odds Ratio estimates) and whose 95% confidence intervals did not include unity. 
The variable that had the highest Odds Ratio was then combined with the variable that had the next 
highest Odds Ratio in the descending order and was put into the multivariate logistic regression 
model with the following co-variates: age, gender, housing status, educational attainment, and total 
urinary arsenic in urine.   
Results 
For both cases and controls, about 60% individuals were less than 40 years old, and more than 60% 
were men. Cases and controls were comparable in their housing accommodation types and 
educational attainments. About 51% lived in cobs or houses made with clay and straw; 30.7% cases 
and 27.2% controls had no formal education (Table 1). Cases had lower InAs% and higher DMA% 
in their urine, indicating that their overall methylation capacities were higher than controls (Table 
2).  
For dietary intakes of Vitamin A, Iron, Fibre, Animal Fat and Beta-cryptoxanthine, compared to 
individuals who were in the highest quintiles of either dietary intakes or serum concentrations (as in 
case of Beta-cryptoxanthine), individuals who were in the lowest quintiles were at higher risk of 
skin lesions. In the unadjusted models, compared to those in the highest quintiles of dietary intakes 
of vitamin A, those who were in the lowest quintiles of Vitamin A dietary intakes were about 23% 
more likely to suffer from arsenic-caused skin lesions (Odds Ratio: 1.23, 95% Confidence interval: 
1.19 - 9.90). Compared to those individuals who were in the highest quintiles of dietary iron 
intakes, those who were in the lowest quintiles were about 2.7 times likely (OR = 2.68; 95% CI: 
1.34 - 5.35), compared to those in the highest quintiles of dietary fibre intakes, those who were in 
the lowest quintiles were about 2.5 times as likely (OR = 2.45; 95% CI: 1.25 - 4.81), people in the 
lowest quintiles for dietary Animal Fat were 2.1 times (OR = 2.10; 95%CI: 1.11 - 3.97), and those 
who were in the lowest quintiles of dietary calcium intakes were 1.9 times at risk of developing skin 
lesions (OR = 1.91; 95% CI: 1.03 - 3.52).  
When these variables were added sequentially to the multivariate logistic regression models, we 
found that even after adjustment of all other variables and other co-variates, dietary Vitamin A and 
serum beta cryptoxanthine were the only variables that maintained their association with the case 
control status.  

Discussion 
We found that when the dietary variables and serum micronutrients were considered together in a 
multivariate model containing demographic variables, socioeconomic status, arsenic exposure 
variables, and other dietary and micornutrients, dietary intakes of vitamin A and serum beta 
cryptoxanthine were associated with increased risk of arsenic-caused skin lesions among arsenic-
exposed population. Compared to those who were in the highest quintiles of dietary Vitamin A 
intakes, those who were in the lowest quintiles were 3.43 times at risk of skin lesions (OR = 343, 
95% CI: 1.19 -9.90), and compared to those who were in the highest quintiles of serum 
Betacryptoxanthine levels, those who were in the lowest levels were about twice at risk of skin 
lesions (OR = 2.07, 95% CI: 1.05 - 4.05). These associations were not influenced even after 
adjustment for the effects of housing status, educational attainment, indicators of arsenic exposure 
and effects of all other dietary variables and serum micronutrients. Additionally, when the quintiles 
of dietary intakes of Vitamin A and beta cryptoxantine were plotted against the odds ratios of skin 
lesions, they showed a decreasing slope of the risk with increase in the quintiles of dietary Vitamin 
A and serum betacryptoxanthine. 
This study derived its strength from its large sample size, nesting of cases and controls within a 
large cross-sectional survey that was aimed to minimize possible measurement biases, and use of 
multivariate logistic regression incorporating quintiles of dietary and serum micronutrients together 
in the same model with other co-variates. The study was based on on 180 cases and 192 controls, 
derived from a large cross sectional survey of about 7683 individuals, who were examined in a 
house to house survey. The dietary status of each individual enrolled in the study was ascertained 
from the eldest female member of the family, or the person who prepared the food for the family. 
The process of determination of serum levels of micronutrients was separate from the process of 
field data collection. Physicians, who determined the skin lesion status in the clinics following data 
collection from the fields, had no knowledge of the dietary status of the participants. Finally, since 
this was a population with low literacy levels, respondents had no knowledge about the dietary 
constituents of their food item.  
Other studies on only dietary or micronutrient variables have also found that low dietary intakes of 
vitamin A and low serum levels of antioxidants (betacryptoxanthine) as risk factors.  
Conclusion 
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Table 1. Comparisons of cases and controls with respect to their age distribution, gender, housing 
and educatioal attainment as measures of demographic and socioeconomic status. The pvalues in 
this table indicate p value for the one way test of trend in the percentages for cases and controls 
Table 2. Comparison between percentiles of percent fractions of excreted inorganic arsenic, MMA, 






Age in years Matched
less than 20 34 16.04 27 14.06
20-39 82 38.68 83 43.23
40-59 70 33.02 60 31.25
60 and above 26 12.26 22 11.46
Gender Matched
female 76 35.68 73 38.02
male 137 64.32 119 61.98
House type 0.37
kacha 110 51.64 99 51.56
pucca 28 13.15 30 15.63
semipucca 75 35.21 63 32.81
Educational Status 0.27
no formal 58 27.23 59 30.73
high school and above 11 5.16 9 4.69
primary 103 48.36 97 50.52
secondary 41 19.25 27 14.06
Variable Quintile Cases % Controls % pvalue
InAs% 0.01
Lowest 49 25.52 31 14.83
Q2 43 22.4 37 17.7
Q3 32 16.67 48 22.97
Q4 33 17.19 47 22.49
Highest 35 18.23 46 22.01
MMA% 0.3
Lowest 33 17.19 47 22.49
2 43 22.4 37 17.7
3 37 19.27 43 20.57
4 40 20.83 40 19.14
Table 3. List of dietary and serum micronutrient variables and their differences in median, 10th and 
90th percentiles between cases and controls. The p-values are based on nonparametric Wilcoxon 
rank sum tests. 
Highest 39 20.31 42 20.1
DMA% 0.06
Lowest 36 18.75 44 21.05
Q2 31 16.15 49 23.45
Q3 40 20.83 40 19.14
Q4 37 19.27 43 20.57



















Glucose 81.5 53.8 129.1 81 55 113 0.09
Serum 
Cholesterol 153.5 110.9 198 149 114 207.4 0.49
Serum 
Transthyreti
n 235 162.7 307 240 173 306 0.19
Serum 
Vitamin 
B12 376 218.7 712 383 216.4 674.4 0.43
Folate 2.85 1.35 5.6 2.6 1.5 5.6 0.1
Selen 1.15 0.71 1.73 1.15 0.66 1.75 0.25
Cysteine 214 175.6 260 212 166 261 0.3
GlutGSSG 2.76 1.29 4.98 2.32 1.16 5.09 0.11
GlutGSH 5.52 2.57 9.95 4.64 2.32 10.17 0.11
Homocyst 12.7 8.18 21.16 13 8.63 23.53 0.22
Retinol 32.8 19.02 47.86 34 21.5 48.44 0.13
Atoc 597 439.6 870.6 594.5 408.1 910.4 0.42
LutZea 61 34 99.6 61.5 32.6 104 0.4
Bcrypt 3.86 1.76 13.7 4 1.5 11.12 0.39
Lycopene 2 0.55 6.8 1.8 0.45 7.87 0.44
BetaCar 55.9 18.88 220.14 50.7 21.06 132.05 0.19
Vit.B6 34.3 20 51.5 34.95 21.8 58.22 0.05
Methion 19.15 13.11 26.33 18.8 12.5 26.8 0.31
Proteinan 3.32 0.81 8.66 4.1 1.32 9.41 0.01
Protnveg 19.6 16.77 23.55 19.34 16.59 25.03 0.27
Table 4. Results of single variable logistic regression where case control status was regressed on the 
standardized dietary variables and serum micronutrients after controlling for the effects of age in 
years, and gender. Standardized beta coefficients and associated pvalues for the regression models 
are shown here, along with mean and standard deviations of the corresponding variables for the 
controls. 
Fatanimal 0.93 0.17 5.11 1.27 0.18 4.53 0.14
Fatveg 8.53 3.64 17.02 8.35 4.39 17.5 0.38
carbohydr 203.22 175.64 218.23 201.91 174.09 214.6 0.12
fibre 1.93 1.09 3.49 2.1 1.1 4.59 0.04
calcium 175.36 71.28 402.32 210.93 99.29 405.2 0
phosph 467.05 406.12 641.46 481.22 413.13 657.46 0.07
iron 5.59 3.89 8.69 5.9 3.75 9.98 0.12
zinc 4.08 3.42 4.69 4.01 3.37 4.86 0.13
carotene 271.56 47.12 4294.55 344.35 52.23 6070.76 0.1
VitA 12.36 0 72.18 14.55 0 64.43 0.4
thyamine 0.63 0.56 0.83 0.63 0.55 0.87 0.18
riboflavin 0.25 0.16 0.48 0.26 0.16 0.45 0.14
niacin 9.92 8.28 10.82 10.01 8.11 10.81 0.48
VitB6 0.58 0.43 0.68 0.56 0.4 0.71 0.13
Folicfree 26.96 21.68 41.42 28.05 20.48 42.13 0.34
Folictotal 61.25 37.01 119.83 65.53 38.15 129.77 0.06
VitC 31.7 11.85 100.99 37.28 13.75 134.57 0.03
Totalnitr 2.68 1.85 3.39 2.62 1.73 3.25 0.13
arginine 1544.92 924.04 1933.86 1491.73 865.73 1846.83 0.05
histidine 478.82 312.2 613.83 468.22 282.46 596.85 0.09
lysine 723.58 507.15 1061.36 698.9 464.1 1037.43 0.16
tryptophan 193.71 137.24 250.37 189.36 123.93 247.7 0.11
phenylana 899.75 597.99 1123.86 880.68 533.63 1094.99 0.06
tyrosine 731.35 484.37 912.74 711.47 438.99 887.08 0.05
methionin 497.21 332.92 617.22 482.83 286.19 606.33 0.13
cystine 247.55 165.38 306.24 246.42 149 305.65 0.07
threonine 745.93 507.35 935.7 726.88 442.53 917.24 0.09
leucine 1429.34 962.99 1819.52 1400.09 887.57 1765.49 0.07
isoleucine 821.87 565.35 1056.1 809 523.15 1047.68 0.12
valine 1147.87 761.75 1424.45 1119.62 668.79 1398.3 0.07
Mean SD Beta Pvalue
Glucose 82.056 26.402 0.222 0.049
Chol 155.777 36.065 -0.076 0.489
Trans 239.563 49.258 -0.093 0.382
Vit.B12 439.636 382.256 -0.047 0.663
Folate 3.346 3.084 0.020 0.853
Selen 1.163 0.430 0.044 0.673
Cysteine 214.170 37.988 0.019 0.868
GlutGSSG 3.240 3.332 -0.062 0.561
GlutGSH 6.480 6.664 -0.062 0.561
Homocyst 15.047 8.398 -0.070 0.520
Retinol 34.766 10.640 -0.134 0.201
Atoc 634.351 216.530 -0.010 0.928
LutZea 66.928 31.235 -0.042 0.692
Bcrypt 5.534 4.716 0.064 0.552
Lycopene 3.612 5.805 -0.132 0.247
BetaCar 69.072 61.923 0.368 0.005
Vit.B6 44.597 60.724 -0.436 0.090
Methion 19.321 5.824 0.042 0.695
Proteinan 4.817 3.394 -0.168 0.109
Protnveg 19.991 3.598 -0.005 0.962
Fatanimal 1.904 1.999 -0.023 0.821
Fatveg 10.095 6.296 -0.083 0.409
carbohydr 197.712 16.679 0.115 0.263
fibre 2.572 1.638 -0.281 0.010
calcium 236.305 140.463 -0.199 0.061
phosph 512.153 107.457 -0.146 0.160
iron 6.521 2.768 -0.206 0.053




VitA 25.239 32.034 -0.019 0.850
thyamine 0.666 0.134 -0.023 0.820
riboflavin 0.289 0.122 -0.046 0.653
niacin 9.716 1.111 0.032 0.748
VitB6 0.556 0.122 0.086 0.387
Folicfree 30.380 10.270 0.012 0.901
Folictotal 77.433 42.208 -0.174 0.093
VitC 57.208 58.809 -0.251 0.024
Totalnitr 2.573 0.658 0.122 0.233
arginine 1437.403 384.645 0.166 0.107
Table 5. Correlation matrix of the seven highest associated (in terms of the standardized betas in 
logistic regression model) dietary variables and serum micronutrients 
Table 5. Results of multivariate logistic regression where case control status was regressed on the 
standardized selected dietary variables and serum micronutrients after controlling for the effects of 
age, gender, housing, educational attainment, urinary percentage of INAS and MMA. 
histidine 458.452 122.944 0.141 0.165
lysine 737.164 253.095 0.074 0.462
tryptophan 190.858 53.430 0.116 0.250
phenylana 851.369 217.381 0.159 0.120
tyrosine 691.279 177.937 0.167 0.103
methionin 468.611 123.783 0.139 0.177
cystine 236.579 67.271 0.137 0.182
threonine 708.693 182.854 0.140 0.171
leucine 1373.843 358.960 0.151 0.140
isoleucine 796.739 209.481 0.123 0.225
valine 1081.563 272.586 0.158 0.122
Vit.B6 BetaCar fibre VitC iron calcium Folictotal
Vit.B6 1 0.1 -0.01 -0.04 0.03 0.07 -0.01
BetaCar 0.1 1 -0.01 -0.03 0.05 0.35 0.08
fibre -0.01 -0.01 1 0.73 0.32 0.31 0.27
VitC -0.04 -0.03 0.73 1 0.24 0.23 0.3
iron 0.03 0.05 0.32 0.24 1 0.44 0.59
calcium 0.07 0.35 0.31 0.23 0.44 1 0.51
Folictotal -0.01 0.08 0.27 0.3 0.59 0.51 1




D. Iron D. 
Calcium
D. Folate










M1 0.065 (0.546) 0.369 (0.004)
M2 0.366 (0.005) -0.310 
(0.008)




The following is an alternative analysis 
Table 3. Results of single variable models. The first column gives the beta coefficient between the 
highest quintile and the lowest quintile. Here, the highest quintile has been the baseline. Thus the 
first column figure represents compared to those in the highest quintiles of dietary intakes or serum 
micronutrient levels, those who were in the lowest 20th percentiles, how likely were they to report 
with skin lesions. The second column represents the odds ratio and the associated 95% confidence 
intervals 
M4 0.356 (0.007) -0.274 
(0.021)



















































































































































































































































































































































































































































CHAPTER 4: NUTRITIONAL FACTORS AND METHYLATION 
Abstract 
Exposure ot inorgnic arsenic through groundwater supply results in considerable illnesses including 
debilitating skin lesions, cancers, and other non-cancerous diseases. It is believed that high 
monomethyl arsonous acid (MMA) is associated with altered DNA methylaiton and leads to 
cancerous and other adverse effects. Although methylaiton is influenced by micronutrients and it is 
understood that nutritional factors may impact arsenic toxicity, the association between different 
nutritional factors taken together and arsenic methylation patterns is not clear. The purpose of this 
study was to report the impact of nutritional factors on methylationof arsenic.  
A case control study of 192 individuals with arsenic caused skin lesions matched with 213 controls 
was conducted within a large cross sectional survey in the arsenic-endemic regions of West Bengal 
state of India. A total of 23 nutritional factors were assessed on the tertiles of the three indicators of 
arsenic methylation (InAs%, MMA%, and DMA%). A two step examination of the association 
between nutritional factors and indicators of arsenic methylation was conducted. In the first step, 
each of hte three indicators were regressed on the nutritional factors individually; in step two, the 
nutritional factors that were important inthe step I were entered in a series of stepwise multiple 
linear regression models and were assessed for their impact on indicators of arsenic methylation.  
Dietary animal fat, serum folate, serum selenium, and plasma retinol were found to be importantly 
associated with MMA%, while lycoepne was fount to be associated with InAs%.  
These findings suggest that nutritional factors play important roles in the pathway linking 
methylation and health effects and it is possible to address arsenic methylatoin and possibly contain 
arsenic caused skin lesions by nutitional supplementation and other programmes. The role of 
dietary animal fat, arsenic methylaiton and arsenic caused health effects is reported for the first time 




Table 1.  Demographic, socioeconomic, total urinary arsenic and BMI.  Total number N=405. 
Characteristics N % of N InAs % MMA % DMA %
Age in years
    <15 28 6.9 20.4 6.75 72.8
    15-29 91 22.5 23.3 8.41 68.3
    30-44 135 33.4 23.6 8.31 68.1
    45-59 89 21.9 24.8 7.89 67.3
    ≥60 62 15.3 19.5 9.34 71.2
pa 0.19 0.06 0.14
Gender
    Female 154 38.2 24.5 7.02 68.5
    Male 251 61.8 22.2 8.88 68.9
pb 0.05 0.01 0.2
Education
    Non-formal 117 28.9 22.5 8.24 69.3
    Primary 200 49.5 23.5 8.23 68.3
    Secondary 68 16.8 22.8 7.95 69.2
    High School 20 4.9 22.4 8.33 69.3
pa 0.47 0.48 0.46
House-type
    Kacha 205 50.6 22.6 8.33 69.1
    Semi-pucca 138 34.1 24.1 7.85 68.1
    Pucca 58 14.3 22.3 8.51 69.2
    Missing data 4 0.9
pa 0.32 0.25 0.4
Skin Lesions
    Present 213 52.5 21.2 8.32 70.4
pa p-value from test for trend. 
pb p-value from t-test. 
    Absent 192 47.4 24.7 8.07 67.2
pb 0.02 0.56 0.03
BMI
    <16.9 122 30.1 23.5 7.96 68.5
    16.9-19.3 121 29.8 21.3 8.73 70.1
    >19.3 126 31.1 22.2 8.35 69.4
    Missing 36 8.9
pa 0.52 0.42 0.73
Total urinary arsenic (µg/L)
    <14.9 134 33.1 20.4 8.46 71.1
    14.9-56.3 133 32.8 22.5 7.84 69.6
    >56.3 138 34.1 21.5 8.51 69.9
      pa 0.55 0.48 0.71
Table 2. Average intake per day of dietary factors, average plasma and serum concentrations of 
micronutrients, and average urine creatinine concentrations with standard deviations (SD). 
Dietary intake per day Average (SD) Micronutrients Average (SD)
Diet survey Plasma
   Calcium (mg/day) 484 (332)     Alphatocopherol (micro/dl) 636 (214)
   Carbohydrate (g/day) 448 (161)     Betacarotene (microg/dl) 83.6 (97.3)
   Carotene (microg/
day) 3546
(7,161
)     Betacryptoxanthin (microg/dl) 5.74 (5.61)
   Energy (kJ/day) 9204
(3,091
)     Homocysteine (micromol/l) 14.8 (8.1)
   Fat, animal (g/day) 3.91 (4.24)     Lutein-Zeaxanthine (microg/dl) 66.5 (30.6)
   Fat, vegetable (g/
day) 21.8 (14.9)     Lycopene (microg/dl) 3.34 (4.92)
   Fibre (g/day) 5.27 (3.47)     Methionine (micromol/l) 19.4 (5.72)
   Folate (microg/day) 164 (102)     Retinol (micromol/dl) 34.1 (10.9)
   Iron (mg/day) 13.9 (7.04)     Transthyretin (mg/l) 237 (53.1)
   Niacin (mg/day) 22 (8.1)     Vitamin B6 (nmol/l) 40.8 (45.3)
   Phosphorus (mg/day) 1130 (435) Serum
   Protein, animal (g/
day) 9.7 (7.14)     Cholesterol (mg/dl) 155 (35.4)
   Protein, vegetable (g/
day) 45 (17.1)     Cysteine (micromol/l) 215 (37.5)
   Retinol (microg/day) 52.2 (66.1)     Folate (ng/ml) 3.38 (2.84)
   Riboflavin (mg/day) 0.63 (0.33)     Selenium (micromol/l) 1.17 (0.41)
   Thiamin (mg/day) 1.49 (0.56)     Total Glutathione (micromol/l) 6.31 (5.56)
   Vitamin B6 (mg/day) 1.27 (0.52)     Vitamin B12 (pg/ml) 435 (315)
   Vitamin C (mg/day) 111 (115) Urine
   Zinc (mg/day) 9.17 (3.3)     Urine Creatinine (mg/l) 622
(531.8
)
Table 3. Association between dietary variables, micronutrients, and indicators of methylation 
assessed by comparing the average arsenic metabolite percent between the lowest (T1) and 
highest (T3) tertiles of each factor with the p-value from the t-test of the mean difference. 
Metabolite Nutritional factor Q1 Q3
Differenc
e P-value
InAs% Urine creatinine 27.70 19.80 -7.81 0.001
Plasma lycopene 26.33 20.47 -5.86 0.01
Dietary riboflavin 20.92 25.17 4.25 0.04
Serum selenium 19.63 23.74 4.11 0.03
Serum folate 20.36 24.25 3.89 0.04
Plasma vitamin B6 23.49 20.36 -3.13 0.14
Dietary calcium 22.97 25.91 2.94 0.19
Serum lutein-
zeaxanthine 23.89 20.95 -2.94 0.14
MMA% Dietary animal fat 7.000 9.330 2.330 0.001
Serum retinol 7.324 9.232 1.908 0.001
Serum homocysteine 7.315 9.179 1.864 0.002
Dietary retinol 7.320 9.133 1.813 0.004
Dietary animal protein 6.964 8.661 1.696 0.003
Serum folate 9.633 7.955 -1.678 0.007
Urine creatinine 7.210 8.720 1.510 0.004
Serum selenium 9.204 7.741 -1.462 0.016
Serum alphatocopheral 7.973 9.107 1.134 0.066
Serum 
betacryptoxanthine 7.304 8.357 1.053 0.072
Serum vitamin B6 7.729 8.718 0.989 0.106
Serum methionine 7.821 8.761 0.940 0.109
Dietary phosphorus 7.246 8.096 0.850 0.145
Dietary carbohydrate 8.570 7.757 -0.814 0.147
DMA% Urine creatinine 64.20 71.40 7.22 0.001
Dietary riboflavin 70.54 65.94 -4.60 0.03
Serum lycopene 65.35 69.62 4.27 0.07
Serum lutein-
zeaxanthine 65.94 69.90 3.96 0.06
Table 4. Results of multivariate analysis of nutritional factors measured in plasma (p), serum(s) 
diet(d) and in urine(u) with indicators of methylation in the model (covariates included in all 
models: age, gender, housing, education, skin lesion status, total urinary arsenic, and BMI). The 
beta coefficients correspond to that of the highest tertile (reference category: lowest or first 
tertile of the corresponding nutritional factor). 
Table 6: Demographic, socioeconomic, methylation and skin lesion status 












InAs Models MMA Models
   InAs1 creatinine(u) -4.56 0.08    MMA1 creatinine(u) -0.66 0.350
lycopene(p) -4.91 0.03 animal fat(d) -2.27 0.001
   InAs2 creatinine(u) -4.10 0.14    MMA2 creatinine(u) -0.84 0.260
lycopene(p) -6.23 0.02 animal fat(d) -2.01 0.003
riboflavin(d) -5.89 0.02 retinol(p) -1.52 0.030
   InAs3 creatinine(u) -3.38 0.20    MMA3 creatinine(u) -0.95 0.240
lycopene(p) -5.25 0.04 animal fat(d) -1.88 0.010




   MMA4 creatinine(u) -0.87 0.280
DMA Models animal fat(d) -2.18 0.003
   DMA1 creatinine(u) -5.39 0.04 retinol(p) -1.34 0.070
riboflavin(d) -3.29 0.17 folate(s) -0.96 0.210
   DMA2 creatinine(u) -5.67 0.04    MMA5 creatinine(u) -0.56 0.460
riboflavin(d) -3.77 0.15 animal fat(d) -2.25 0.002
lycopene(p) -3.91 0.13 retinol(p) -1.69 0.002
selenium(s) -1.56 0.030
   MMA6 creatinine(u) -0.52 0.530




Table 8: Results of multivariate linear regression models between 
nutritional factors and methylation 
Discussion 
Draft Paper  (this article is planned to be submitted to Environmental Health Perspectives. The 
references are not yet properly formatted according to EHP styles, but will be formatted once 
additional refs are added and the paper is finalized. Apologies for inconvenience. – Arindam Basu) 
Relationship between diet, micronutrients, and patterns of arsenic 
methylation in West Bengal, India 
Abstract 
Background: Methylation may have an important role in arsenic toxicity based on evidence that the 
monomethylated trivalent metabolite (MMAIII) is more toxic than inorganic arsenic itself. It is 
therefore important to identify factors that might increase concentrations of MMA by reducing 
further methylation to dimethylated arsenic (DMA).  
Objectives: To investigate the relationship of nutritional factors with methylation patterns of 
arsenic reflected in urine in what we believe is the first comprehensive joint assessment of dietary 
factors and blood micronutrients in a study including persons with and without arsenic skin lesions.  
Methods: We conducted a a cross-sectional survey of an arsenic-exposed population in West 
Bengal including 192 persons with aresnic-caused skin lesions and 213 persons without. We 
assessed 30 dietary factors obtained from 24-hour recall, and 16 blood micronutrients. Bivariate and 
multivariate linear regression models were used to identify associations of indicators of arsenic 
methylation in urine with dietary factors and serum micronutrients, adjusting for age, gender, 
socioeconomic variables, body mass index, total urinary arsenic and skin lesion status.  
Results: The strongest associations found involved MMA% which was positively related to the 
intake of animal fat (standardized beta = 0.249; p = 0.001), and negatively related to serum folate 
(standardized beta = -0.246; p = 0.001). MMA% was also positively associated with serum 
homocysteine concentrations (p=0.03), but this associaton disappeared when serum folate was 
adjusted for in the model. 
Conclusions: This study provides further evidence that folate intake reduces concentrations of 
MMA. The finding that high intake of animal fat increases MMA concentrations is new.  
[Note to Allan: I deleted the reference to the opinion that it could be related to fish consumption 
because we did not find any association between fish related fat and any of the indicators of aresnic 




There is considerable in vitro evidence suggesting that monomethylated trivalent arsenic (MMAIII) 
is a highly toxic metabolite produced following ingestion of inorganic arsenic [20, 10]. Factors that 
influence arsenic methylation may therefore be important determinants of susceptibility to health 
effects resulting from the presence of inorganic arsenic in drinking water. In the state of West 
Bengal, India and adjoining Bangladesh, about 80 million individuals have been exposed to high 
concentrations of inorganic arsenic in tubewell water [3, 6, 11]. In view of widespread poor 
nutrition, dietary factors which might increase arsenic toxicity are an important topic for study in 
this population.  
Inorganic arsenic in drinking water exists in trivalent, and pentavalent forms, As(III) and As(V). 
After ingestion, As(V) is reduced to As(III), followed by sequential reduction-methylation reaction 
steps resulting in formation of MMA(III), MMA(V), DMA(III) and DMA(V) [1, 12]. However, this 
process is incomplete, and considerable variability exists within populations in the proportions of 
inorganic arsenic and the methylated arsenicals excreted in urine. Methylation was once believed to 
be a process of detoxification of arsenic [7, 1], but current evidence following isolation and 
characterization of MMA(III) indicates that the first step of methylation which produces of MMA 
should really be thought of as an activation step, while the conversion of MMA to DMA in a second 
methylation step would reduce toxicity. In addition to the in vitro toxicity studies, recent human 
studies have found evidence of increased risks of skin and bladder cancer related for persons with 
higher proportions of MMA in their urine [4]. Human data concerning MMAIII itself are difficult to 
obtain because it is unstable and rapidly oxides to MMA(V), but it is reasonable to believe that 
persons with high concentrations of total MMA in urine could also have had high internal 
concentration of MMA(III) [2, 1] 
Evidence is mounting that dietary constituents and blood micronutrients are related to the 
methylation of inorganic arsenic. We previously reported on the relationship between diet and 
methylation in a study in the Western United States and found low protein intake associated with an 
increased proportion of arsenic as MMA in urine [18]. A study in Bangladesh involving plasma 
micronutrients found low folate and high homocysteine concentrations to be associated with higher 
proportions of MMA in urine [8], and a dietary study found that reduced intake of folate related 
nutrients were associated with higher proportions of MMA [17]. Furthermore, folic acid 
supplementation with concurrent exposure to arsenice in water resulted in a decrease in the 
proportion arsenic which was in the form of MMA [9] 
We have previously reported on the relationship of dietary constituents [12] and blood 
micronutrients with arsenic-caused skin lesions in West Bengal [6]. Here, we report the findings 
concerning 46 dietary constituents and blood micronutrients with arsenic methylation patterns in 
urine in what we believe is the first comprehensive joint assessment of a large number of both 




We conducted a cross-sectional investigation of 180 cases who had skin lesions and 192 persons 
who did not have skin lesions, in the North 24 Parganas district, of the state of West Bengal in 
India, between 1998 and 2000.  
Participants had been selected for a previously completed case-control study of arsenic-caused 
skin lesions [11]. The study base for selection of cases and controls involved 7683 individuals who 
participated in a 1995-1996 population based cross-sectional survey of the South 24 Parganas, a 
rural district located south of Kolkata. The survey identified 415 individuals with signs of arsenic-
induced skin lesions [10]. Water samples were collected from the primary current drinking-water 
source of each participant. Because of our interest in examining effects at low doses, we based the 
case-control study on survey participants whose primary drinking water sources contained less than 
500 micrograms/liter of inorganic arsenic (N = 4815, 2160 females and 2025 males). The study 
involved 180 cases and 192 controls. Cases were individuals who had a positive skin lesion 
classification, with either hyperpigmentation (mottled dark brown pigmentation bilaterally 
distributed on the trunk) or keratoses (diffuse thickening of palms or soles, with or without nodules) 
at the time of survey. Controls were randomly selected from the study base, and matched to the 
cases by gender and age within 4 years. The study protocol was approved by the Institutional 
Review Boards of the Institute of Post Graduate Medical Education and Research, Kolkata and the 
University of California, Berkeley. Informed consent was obtained from all participants.  
The current investigation we report here uses cross-sectional data from the cases and controls 
including dietary assessment, measurement of blood micronutrients, and measurement of 
methylated arsenic species in urine samples. The controls were selected to be representative of the 
source population as described above. Cases with skin lesions are included in the present analysis to 
increase the numbers of participants. As explained below, we checked for possible distortion of 
associations between nutritional factors and arsenic methylation patterns due to the inclusion of 
both cases and controls. 
Assessment of dietary intake and blood micronutrients  
For each participant, we meaured weight and height and calculated body mass index (BMI). We 
ascertained food intake for each participant with a detailed questionnaire based primarily on 24-
hour recall. We have previously presented the methods used for dietary assessment [12]. In brief, 
the senior woman, who in this population directs preparing food for the family, was interviewed. 
The senior woman, who was usually the mother in the family or the eldest daughter-in-law, was 
questioned about each meal from the previous day’s lunch through to the breakfast on the day of the 
interview. The volume of each cooked food was assessed by questioning the senior woman using 
standard cups and plates. Standard sized spoons were used to assess the intake of sugar and oil. We 
asked about weekly consumptions of meat, fish, eggs, milk, and fruit because these items were not 
consumed on a daily basis. The 1-week intake of these food items was then divided by 7 to compute 
the average intake per day. We calculated total 24 hour intake of each nutrient using a spreadsheet 
program based on food composition tables.  
Field physicians interviewed participants using a structured questionnaire, conducted a general 
examination, and obtained blood samples from each participant when they were visited in their 
homes. We have previously presented detailed information concerning storage and analysis of blood 
samples [6]. In brief, nonfasting blood samples were collected and stored in an ice chest in the field. 
Aliquots were prepared within 24 hours, frozen at -20 deg C in India, later transported to the United 
States on dry ice where they were stored at -70 deg C until laboratory analysis. Pacific Biometrics 
(Seattle, WA) conducted most serum and plasma analyses for the micronutrients and biochemical 
indicators, or in some instances arranged for them to be done at a different laboratory. Plasma 
measurements included homocysteine, glutathione, cysteine, methionine, vitamin B6, retinol 
(Vitamin A), alpha-tocopherol (Vitamin E), alpha-carotene, beta-carotene, lycopene, lutein-
zeaxanthin, and beta-cryptodextrin.  
Serum measurements included glucose, cholesterol, vitamin B12, folate, transthyretin, and 
selenium. 
Measurement of urinary arsenic 
The urinary concentrations of arsenic were measured using hydride generation atomic absorption 
spectroscopy. In this technique, InAs, MMA, and DMA were reduced to the corresponding arsine in 
a batch reactor using sodium borohydride in 5 ml samples. The volatile reduction products (arsenic, 
methyl arsine, and dimethylarsine) were removed by sparging with helium. Entrained arsines were 
concentrated in a chromosorb-filled cryogenic trap in liquid nitrogen temperatures until all arsine-
forming arsenic in the sample had reacted. The cryotrap was then allowed to warm, and the 
collected arsines were separated on the basis of differential volatilization. The separated volatile 
arsenic species were detected with a hydrogen microburner combustion cell to convert arsines to 
elemental arsenic. To prevent interference by other compounds, each urine sample was acidified 
with 2 M HCl and allowed to sit for at least 4 hours. Total arsenic was determined by flow injection 
analysis/atomic fluorescence spectrometry and the result was compared with the sum of the species 
detected. If a significant amount of arsenic remained undetected, additional digestion or assay for 
asenobetaine was performed. Detection limits for InAS, MMA, and DMA were 0.5, 1, and 2 
micrograms/L respectively. Concentrations below the detection limit were set at one half the 
detection limit. The MMA and DMA measured in this study were in the pentavalent forms. The 
trivalent forms, MMA(III) and DMA(III), are rapidly oxidized to MMA(V) and DMA(V) during 
storage. 
Demographic and social variables 
We considered age, gender, type of housing and years of education as demographic and 
socioeconomic covariates. In India, socioeconomic status is commonly measured by the types of 
dwellings, which are correlated with household economic status [15]. In this study, we determined 
socioeconomic status by the dwelling type based on materials used to construct the house, and by 
educational attainment. We considered three classes of houses: pucca houses – built with high 
quality materials, eg bricks or concrete; semi-pucca houses – constructed partly with clay and 
bricks, and kacha – mud houses. 
Statistical methods 
We converted age into a categorical variable; we categorized educational attainment as follows: 
those who did not have formal education, those who studied till primary level (primary: about 4 
years of formal education), those who attained high school but did not study beyond high school 
(secondary), and those who completed high school education and studied beyond (high school 
plus). Total urinary arsenic, percentages of inorganic arsenic in urine, percentages of MMA in urine, 
percentages of DMA in urine, and Body Mass Index (bmi) were categorized into quintiles. The 
status of skin lesions ("disease status") was based on the presence or absence of characteristic skin 
lesions attributed to caused by exposure to inorganic arsenic.  
We cross-tabulated each categorical variable with indicators of methylation – percentages of 
inorganic arsenic (InAs%), MMA (MMA%) and DMA (DMA%) in urine and conducted tests for 
trends across the strata of each variable..  
We analyzed 30 dietary factors and 16 blood level micronutrients. To remove outliers, we 
transformed all 46 dietary and micronutrient variables into their natural logarithms and removed all 
values that were 3 standard deviations below or above mean. The remaining values, retained for 
analysis, were then back transformed to their natural values and entered into further analyses.  
We then regressed each indicator of methylation (urinary percentages of inoragnic arsenic, 
MMA, and DMA) on each dietary factor and blood micronutrient using a series of bivariate linear 
regressions. For each pair of bivariate linear regression, we calculated the standardized beta 
coefficient and the associated p-value.  
We then selected a particular dietary factor or blood micronutrient to be included in a series of 
stepwise multivariate linear regressions as follows. For each pair of bivariate linear regression 
outlined in the above step, the standardized beta and its associated p-value was examined. For any 
particular dietary factor and serum micronutrient, if we found that the p-value associated with the 
beta coefficient was less than 0.05, we retained this dietary factor or serum micronutrient for further 
input to the series of multivariate reactions. We also calculated a correlation matrix of the selected 
dietary factors and serum micronutrients examine their collinearity with each other. 
We then entered the selected dietary factors and the blood micronutrients in a series of 
multivariate linear regressions. The first outcome variable we considered was InAs%. The 
explanatory variables were entered in order of the magnitude, denoted by the absolute value of their 
standardized beta coefficient obtained during the bivariate regressions. The variables were added in 
a stepwise manner in decreasing order of beta coefficient values. We retained a variable if in the 
multivariate model, we found that the associated p-value for the variable was less than 0.05. We 
rejected a variable for the next step if p-value for the particular variable exceeded 0.05. We also 
added the following covariates into the multivariate model to deal with potential confounding: age 
in years (categorized), gender, education, housing status, total urinary arsenic, and presence or 
otherwise of skin lesions.  

Results 
In this population, about 75% people were aged between 20 and 59 years and about 63% were men 
(Table 1). Less than 5% of the population had high school or higher education, and about 14% lived 
in houses made of bricks. More than 50% of this population lived in kacha houses (houses 
constructed with clay). The median total urinary arsenic level was 128 microgram/L and the median 
values for urinary arsenic metabolites were 15.9%(InAs%), 6.6%(MMA%), 69.9%(DMA%) (Table 
1).  
Male gender and presence of skin lesions were associated with reduced output of InAs% and 
increased output of MMA% in urine, indicating increase in the first stpe of methylation to MMA, 
and decrease in the second to DMA.. Men had lower InAs% (men: 22.2%, women: 24.5%; p=0.05) 
and higher MMA% than women (men: 8.88, women: 7.02% ; p=0.01). Those who had skin lesions 
had lower InAs% (21.3% versus 24.3% for those with no skin lesions; p=0.03), and higher DMA% 
in urine (70.4% for those with skin lesions and 67.3% for those with no skin lesions). In summary, 
male gender and presence of arsenic-caused skin lesions were associated with increased 
methylation (Table 2).  
From our bivariate linear regression models, we found nine dietary variables and three serum 
micronutrients had standardized beta coefficients with p-values lower than 0.05. These variables are 
described for each indicator of methylation in decreasing order of their standardized beta 
coefficients. For inorganic arsenic percentages, these were Serum Folate (beta = 0.392) with  and 
Serum Selenium (beta = 0.219). For urinary MMA%, these were:  Serum Folate (beta = -0.526), 
Dietary Animal Fat (beta = 0.440), Dietary Riboflavine (beta = 0.424), Dietary Animal Protein (beta 
= 0.298), Dietary Phosphate (beta = 0.297), Dietary Vitamin A (beta = 0.279), Serum Selenium 
(beta = -0.249), Dietary Calcium (beta = 0.245), Serum Homocysteine (beta = 0.234), Dietary 
Lysine (beta = 0.194), Dietary Fiber (0.191), and Dietary Thiamin (beta = 0.188). For DMA%, we 
found  Serum Folate (beta = -0.263) and Serum Selenium (beta = -0.160) to have p-values less than 
0.05 (Table 3). 
In multivariate linear regression models, after controlling for the effects of age, gender, 
socioeconomic status, body mass index, arsenic exposure levels and presence of skin lesions, we 
found that Dietary Animal Fat and Dietary Phosphate were positively associated with MMA% and 
Serum Folate and Serum Selenium were negatively associated with MMA%. We also found Serum 
Folate and Serum Selenium positively associated with InAs%. When combined with different 
dietary variables and serum micronutrients, the standardized multivariate beta for Serum Folate 
varied between -0.363 to -0.263, indicating relative resilience of Serum Folate to the effects of other 
dietary variables and serum micronutrients. When combined with different dietary and serum 
micronutrients, the standardized multivariate beta for Dietary Animal Fat varied between 0.272 and 
0.442, indicating relative resilience of Dietary Animal Fat to the effects of all other variables. In the 
model where Serum Folate and Dietary Animal Fat were put together, beta of Serum Folate was 
-0.305, or about 60% increment towards null, while that of Dietary Animal Fat was 0.442, 
indicating that even after adjustment for the effects of Serum Folate, the effect of Dietary Animal 
Fat was strong on MMA%. While Dietary Animal Fat was strongly correlated with Egg and Fish 
Fat, it had low correlation with Meat Fat. Egg fat, Fish fat and Meat derived Fat were not 
considered in the models. When Serum Folate and Serum Homocysteine were put in the same 
model, beta coefficients of both the variables were reduced; however, Serum Homocysteine had 
minimal loss of beta when put in multivariate models in combination with other dietary and 
micronutrients excluding Serum Folate. Serum Folate and Serum Homocysteine were moderately 
correlated with each other (correlation coefficient = -0.298). Serum Selenium was negatively 
correlated with MMA% but positively correlated with InAs%. The positive association of Serum 
Selenium persisted even after adjustment of all other variables including that of Serum Folate 
(Table 5) 
Discussion 
Increased dietary intake of Animal Fat was associated with increased MMA% in urine, while 
increased serum levels of Folate and Selenium were associated with decreased urinary MMA%. In 
addition, increased Serum Selenium was associated with increased urinary InAs%. When these 
findings were considered together, these tend to suggest that, increased dietary intake of Dietary 
Animal Fat may be associated with increased Arsenic Methylation with high proportional 
respresentation of MMA in urine, while high serum levels of Folate and Selenium would likely to 
reduce InAs conversion to MMA, resulting in reduced proportion of MMA and higher relative 
proportion of inorganic arsenic. High dietary intake of Animal Fat and Animal Protein were 
associated with increased urinary MMA%; dietary Animal Protein and Animal Fat were also highly 
correlated with each other (r = 0.611; p = 0.03). When MMA% was regressed on Dietary Animal 
Protein and Dietary Animal Fat together in the multivariate regression model, the effect of dietary 
Animal Fat persisted while that of dietary Animal Protein was diminished, indicating that even after 
adjusting for the effects of other dietary factors, dietary intake of Animal Fat had an indepedent 
association with a methylation state that increased urinary MMA%.  
This was a large population based study (N = 406) conducted in rural West Bengal among a 
population that was exposed to inorganic arsenic in groundwater exceeding 50 micrograms/Liter. 
The field investigators estimated the dietary factors in the field, and at the time of conducting the 
diet survey, they were not aware of the methylation status of the participants; in addition, estimation 
of urinary levels of arsenic metabolites and serum micronutrients were done separately, thus 
removing any possible observation or measurement bias. In addition to dietary  Animal Fat, Animal 
Protein, serum Folate, and serum Selenium, other dietary variables and micronutreints considered 
for the multivariate models were: dietary Fiber, Phosphate, Riboflavine, Vitamin A, Lysine, 
Calcium, Thiamine, and serum Homocysteine. We tested the effects of all these other dietary factors 
and serum levels of micronutrients in a series of multivariate models. In these models, we added 
age, gender, socioeconomic status, body mass index, total urinary arsenic (as a measure of arsenic 
exposure) and skin lesions as additional covariates. Serum Homocysteine dropped out of 
multivariate models when added in combination with dietary Animal Fat and Serum Folate levels. 
Presence of these associations in the context of large sample sizes, objectivity in the measurements 
and blinding of the investigators as to the status of methylation and serum levels of micronutrients, 
and persistence of effects in multivariate models suggest that the observed associations between 
MMA%, dietary Animal Fat, Serum Selenium, and Serum Folate levels, and associations between 
urinary InAs%, and serum Selenium, were real.  
In vivo methylation of inorganic arsenic uses S-adenosyl methionine (SAM) as the methyl group 
donor, and the end results of all SAM dependent methylation reactions are methylated arsenic 
products and the SAH (s-adenosylhomocysteine). SAH is then converted to homocysteine in a 
rapidly reversible reaction. Even mild increments in plasma homocysteine levels are associated with 
linear increments in SAH levels. SAH also act as rate limiting inhibitor of the methylation, by 
tightly binding to methyltransferases and is only removed with downstream removal of 
homocysteine, which occurs with folate supplementation or with increasing folate levels. We found 
that Homocysteine (serum) was positively correlated with MMA% (beta = 0.234; p = 0.04 ). 
Homocysteine was also negatively correlated with serum Folate (r = -0.298, p = 0.01). However, 
when both Homocysteine (serum) and Folate (serum) were included in the same regression model, 
the coefficient of Folate (serum) remained unchanged while that of Homocysteine (serum) reduced 
(bivariate beta = 0.19, p= 0.01). In a large cross-sectional survey in a comparable Bangladeshi 
population (N = 1650), Gamble reported negative association between serum Folate with MMA% (r 
= -0.12; p = 0.04) and positive association between serum Homocysteine and urinary MMA% (r = 
0.21; p < 0.001). However they did not analyze the data adjusting for each other.whne looking at 
MMA%.  
The association between high dietary intake of Animal Fat and high urinary MMA% was 
surprising before this was not reported before, and we did not find any prior published research that 
explained any biological role of dietary animal fat in affecting arsenic methylation. When we 
regressed urinary MMA% on dietary Animal Fat and dietary Animal Protein together in the 
multivariate regression model, beta coefficient of dietary Animal Fat remained unchanged from the 
bivariate beta coefficient, while that of the dietary Animal Protein reduced. Thus, the effect of 
dietary Animal Fat on urinary MMA% was an independent effect that persisted even after 
adjustment for the effects of all other variables. There has been no prior report of the association 
between dietary Animal Fat and increased MMA%, and ours is the first report of this association. 
While the biological significance or mechanism by which dietary intake of Animal Fat may impact 
urinary MMA% is unclear, we also know that in this population, fish intake was the major 
contributor to the dietary Animal Fat concentration (data not shown).  
The findings of this study need be interpreted in the light of its several limitations. First, 
although we found associations between dietary Animal Fat, serum Folate, and serum Selenium 
with urinary MMA% and serum Selenium with InAs% , the magnitude of these associations were 
weak, based on standardized beta coefficients as measure of the slope of the linear association, 
indicating at best modest effects. Second, since this was a cross-sectional survey, information on the 
dietary factors were collected at the same time as blood was sampled for estimation of serum 
micronutrients and urine samples were collected for estimation of urinary InAs%, MMA%, and 
DMA%. Because of the complex inter-relationships between arsenic methylation reactions and 
micronutrients including Folate (serum), and Homocysteine (serum), involving transmission of 
methyl groups, it could not be ascertained only on the basis of a cross-sectional study whether the 
changes in either dietary intake of Animal Fat, or levels of Homocysteine, Folate (serum), or serum 
Selenium preceded the changes in the levels of urinary arsenic metabolites. Third, we obtained data 
on dietary factors using a diet based food frequency questionnaire based on 24 hours recall, with the 
tacit assumption that the dietary patterns of people in this population remained unchanged for a long 
time. While this assumption may have been a valid assumption in view of this stable, rural 
population, this assumption may not be tenable in other populations that have more variations in 
dietary intake of items over time.  
In summary, while this study had several limitations, the findings suggested that serum Folate, 
serum Selenium, and dietary Animal Fat may be important independent factors that explained 
variability of urinary MMA% and InAs% and thereby overall methylation of arsenic among 
individuals who lived in high exposure areas. The findings that dietary Animal Fat may be linked to 
Arsenic methylation was unexpected, particularly in view of the observations that although majority 
of the Animal Fat intake could be explained by dietary Fish Fat intake rather than dietary Meat 
intake, neither Fish Fat nor Meat Fat had associations with Arsenic Methylation. These need to be 
further characterized in future studies linking dietary patterns contributing to arsenic toxicity among 
populations exposed to high Arsenic. 
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CHAPTER 5: METHYLATION AND SKIN LESIONS 
Abstract 
Background. – Worldwide, exposure to high concentrations of inorganic arsenic through drinking 
water accounts for considerable mortality and morbidity. It is believed that increased methylation of 
arsenic, leading to generation of MMA(III), increases the risk of arsenic toxicity. While the role of 
methylation has been studied in the context of arsenic toxicity, relatively little is known about the 
impact of different dietary intakes and blood level micronutrients on arsenic methylation. Here, we 
report the impact of dietary variables and serum micronutrients on arsenic methylation in a 
population known to be exposed to inorganic arsenic. 
Methods. – A case control study on the effects of dietary and serum level variables on arsenic-
caused skin lesions was nested within a larger cross sectional survey. Information on dietary 
variables was obtained through a diet survey questionnaire, and information on blood level 
micronutrients was obtained from sampling during the cross sectional survey. Methylation capacity 
was measured by percent excretion of inorganic arsenic, monomethyl arsonous and arsonic acids 
(MMA), dimethylarsinic acids (DMA) in urine and by calculating the MMA:DMA ratio. 
Adjustments for dietary calorie intakes were done for dietary variables by dividing the dietary 
variables by calorie intake. Levels of calorie-adjusted dietary intake and serum micronutrients were 
calculated by calculating quintiles. Mean values of the indicators of arsenic methylation for the 
lowest and highest quintiles of dietary and micronutrient levels were used to assess the crude 
association between dietary variables, serum micronutrients and methylation capacity. Multivariate 
linear regression models were used where indicators of methylation were regressed on dietary and 
serummicronutrients after adjusint for the effects of age in years, gender, housing status, 
educational attainment, total urinary excreted arsenic. The beta coefficients were used to identify 
the effects of increment or decrement of dietary variables on serum micronutrients on methylation 
status.  
Results. – Older age was associated with increased MMA%, and MMA:DMA ratio; female 
gender was associated with high InAs%,but low MMA% and low MMA:DMA ratio. No effect was 
observed for educational attainment, housing status, or total arsenic excreted in urine. 
Compared to those in the lowest quintiles of calorie adjusted dietary intakes of animal protein, 
animal fat, calcium, phosphate, Vitamin A, Riboflavin, Lysine and Tryptophan, those who were in 
the highest quintiles of these dietary intakes had high MMA% and MMA:DMA ratios. After 
adjustment for age, gender, socioeconomic status, and total urinary arsenic, high MMA percentage 
was positively associated with animal protein intake (beta = 0.16), animal fat (beta = 0.49), calcium 
(beta = 0.004), phosphate (beta = 0.007), vitamin A (beta = 0.026), Riboflavin (beta = 5.5), and 
Lysine (beta = 0.003). Dietary intakes of animal protein (b = 0.34), animal fat(b = 0.88), calcium (b 
= 0.008), phosphates (b = 0.011), Vitamin A (b = 0.047), Riboflavin (b = 11.1) and lysine (b = 
0.005) were positively associated with MMA:DMA ratio.  
Compared to those in the lowest quintiles of blood levels of glucose, folates, and selenium, those 
who were in the highest quintiles had high InAs%; those in the highest quintiles of selenium and 
glucose had low MMA%, low DMA%, and low MMA:DMA ratios. Compared to those in the 
lowest quintiles of blood levels of retinol, Vitamin B6, and methionine, those who were in the 
highest quintiles had higher MMA% and MMA:DMA ratio. Those who were in the highest 
quintiles of homocysteine, had high MMA%. After adjusting for the effects of age, gender, 
socioeconomic status, and total urinary arsenic, blood levels of retinol was negatively associated 
with InAs% (b = -0.15), but positively associated with MMA% (b = 0.06) and MMA:DMA ratio (b 
= 0.09). In the multivariate model, blood selenium was negatively associated with MMA% (b = 
-1.34), and Vitamin B6 was positively associated with MMA% (b = 0.016), and MMA:DMA ratio 
(b = 0.029).  
Discussion. – In summary, high calorie adjusted dietary intakes of animal fat, animal protein, 
Riboflavin, Vitamin A, calcium and phosphates were associated with increased methylation, while 
high blood levels of retinol and Vitamin B6 were associated with increased methylation. High blood 
levels of selenium was associated with low methylation,indicated by low MMA levels. These 
indicate that diet and micronutrients play potentially important roles in the arsenic metabolism and 
warrant further studies. 
Introduction 
Worldwide, millions of people are exposed to high concentrations of inorganic arsenic in their 
drinking water. In the Indian subcontinent alone, about 150 million people in Bangladesh and the 
adjacent areas of the West Bengal state of India in the Ganges delta are exposed to very high 
concentrations of inorganic arsenic in their drinking water [Error: Reference source not found]. 
Exposure to high concentrations of inorganic arsenic is associated with different clinical 
manifestations ranging from skin lesions through systemic illnesses (hypertension, diabetes 
mellitus) to internal cancers (cancers of lung, and urinary bladder). Following entry to human body, 
arsenic undergoes sequential processes of reduction and methylation reactions where the methyl 
groups are donated by S-adenosyl methionine (SAM), resulting in the process of formation of 
different arsenic species and compounds — As(V), As(III), monomethyl arsonous acid (MMA(III)) 
and MMA(V), and dimethyl arsinic acids - DMA(III) and DMA(V) — the roman numerals in the 
parentheses indicating their respective valency states [Error: Reference source not found]. Till 
recently, methylation was believed to be a process of detoxification of arsenic; however, current 
evidence following isolation and characterization of MMA(III) indicate that methylation may not be 
a detoxification process; in fact, methylation can actually increase susceptibility to several arsenic-
caused health effects, in particular, arsenic-caused cancers of skin and urinary bladder [18]. It is 
believed that increased methylation process increases cell-wide DNA hypermethylation, leading to 
deficiency of DNA repairs and inactivation of tumor suppressor proteins. The combined effects of 
altered methylation patterns in the tissues lead to development of tumor formation [Error: Reference 
source not found].Inorganic arsenic, after entry into body, undergoes sequential reduction and 
methylation processes that lead to the formation of monomethyl arsonous acids and dimethylarsinic 
acids — these metabolites are then excreted by the urine. 
Macronutrients and micronutrients have played important roles in the pathogenesis of chronic 
arsenic toxicity. Earlier studies have shown that people with arsenic-caused skin lesions have low 
dietary intakes of animal protein, calcium, and dietary fibers; studies in Taiwan with arsenic caused 
peripheral vascular lesions have suggested that people with arsenic-caused health outcomes have 
low levels of beta carotene. Low levels of selenium have been implicated in enhancing 
susceptibility to arsenic toxicity [12, Error: Reference source not found, 19]. 
There is limited evidence on the inter-relationship between diet, micronutrients, methylation of 
arsenic and clinical outcomes as a result of arsenic exposure. However, arsenic methylation uses 
methionine and homocysteine directly in the metabolic pathway, and several micronutrients may be 
involved as co-factors for the enzymatic reactions during the methylation process. An earlier study 
has suggested that people whose diets are deficient in protein, iron, zinc and niacin show higher 
excretion of MMA and are more susceptible to arsenic-caused cancers [18]. However, little is 
known to the extent micronutrients and dietary factor affect arsenic methylation patterns based on 
human epidemiological studies. The purpose of this paper is to present data on the relationship 
between diet, micronutrients and indicators of arsenic methylation.  

Methods 
We conducted a population based case control study nested within a larger cross-sectional survey of 
an arsenic-endemic region, the North 24 Parganas district, of the state of West Bengal in India. 
Below, we outline the population, exposure variables, comparison groups, and measurements of the 
outcome. 
Base Population. — We targeted two areas within the North 24 Parganas district, West Bengal, 
for this survey. We selected the first area because high levels of arsenic were detected in some, but 
not all, of the shallow tubewells as determined in a prior study [Error: Reference source not found]. 
The second area included the remaining part of the district where people used shallow tubewells for 
the source of their drinking water. The total population of the two araes combined was 150,457. A 
total of 7818 participated in the study, and we obtained water arsenic levels for 7683 individuals 
(98.3%). These 7683 individuals (4093 females and 3590 males) consitute the base population for 
this study. 
In this geographical region, the high exopsure region (where the avearge arsenic level in 
groundwater >= 50 micrograms/l) included 25 villages. The study team went to the center of each 
village and selected the most convenient group of houses to commence sampling. The team invited 
each member of the household present at the time of the interview to participate. They adminitered 
an interview and conducted medical examination. Sampling continued house-to-house in a village 
till the team recruited between 50–150 participants. 
The low exposure region included 32 villages within 16 amdinistrative blocks. We restricted the 
sampling in this region to villages with more than 100 houses. One or more villages were selected 
at random from each of the 16 blocks depending on the population size. While we selected only one 
village for sampling from a small block, if the block was large, we also selected two to three 
villages. As with the high exposure villages, the study team went to the center of each village, and 
selected the most convenient groups of houses to commence sampling. Here, we invited residents of 
every fourth house to participate.  
Eligible population. – The arsenic levels in the groundwater ranged from nondetectable through 
3400 micrograms/liter (mean = 185 micrograms/liter; standard deviation = 290). Because we were 
interested to study effects at low doses, we based this case control study on survey participants 
living in the 21 villages whose primary drinking water sources contained < 500 micrograms/liter of 
inorganic arsenic. We found 4185 individuals (54.5%) who fulfilled these criteria (N = 4185; 2160 
females and 2025 males).  
Participant population. – We labelled cases as all individuals from the cross sectional survey who 
were diagnosed with arsenic-caused skin lesions (described in the next section) and whose main 
water source contained less than 500 micrograms/liter of arsenic. From 4185 individuals who were 
eligible to participate in the study, the participant population was 265 individuals with skin lesions 
(6.3%). Of the 265 identified cases, 174 had pigmentation changes, 15 had keratoses and 76 had 
both types of lesions. Hyperpigmentation is marked by raindrop-shaped discolored spots, diffuse 
dark brown spots, or diffuse darkening of the skin on the limbs and trunk. Simple keratoses usually 
appear as bilateral thickening of the palms and soles. In nodular keratosis, small protrusions emerge 
on the palms and soles, and also occasionally on the dorsum of the hands and feet, or on the legs. 
We selected controls from survey participants who did not have skin keratoses or 
hyperpigmentation when seen during the 1995–1996 survey, and whose main tube well-water 
source, like the cases contained < 500 micrograms/liter of arsenic. For each case, we selected one 
control matched on age (plus or minus 5 years) and sex randomly from all eligible non-cases. We 
selected replacement controls for controls who had died, could not be located or did not wish to 
participate. Of the 530 initial seleced individuals (265 cases and 265 controls), 15 cases were not 
available to participate, 16 individuals (6 cases and 10 controls) moved outside the study region, 54 
(26 cases and 28 controls) could not be located, and 40 individuals (26 cases and 14 controls) were 
either too ill to participate or died or refused to participate. Thus, we recruited 405 individuals (192 
cases and 213 controls) for this study. 
Measurement of urinary arsenic species. – Two to three urine samples were collected from each 
participant over one-year period. Subjects were given screw-top containers and asked to give a 
midstream sample of the first morning void. Samples were then transported on ice to the field 
laboratory each day where they were kept frozen at -20 degree C. Urine samples were transported to 
the University of Washington, Seattle, for analysis.  
The urinary concentrations of arsenic were measured using hydride generation atomic absorption 
spectroscopy. In this technique, InAs, MMA, and DMA were reduced to the corresponding arsine in 
a batch reactor using sodium borohydride in 5 ml samples. The volatile reduction products (arsenic, 
methyl arsine, and dimethylarsine) were removed by sparging with helium. Entrained arsines were 
concentrated in a chromosorb-filled cryogenic trap in liquid nitrogen temperatures until all arsine-
forming arsenic in the sample had reacted. The cryotrap was then allowed to warm, and the 
collected arsines were separated on the basis of differential volatilization. The separated volatile 
arsenic species were detected with a hydrogen microburner combustion cell to convert arsines to 
elemental arsenic. To prevent interference by certain compounds, each urine sample was acidified 
with 2 M HCl and allowed to sit for at least 4 hours. Total arsenic was determined by flow injection 
analysis/atomic fluorescence spectrometry and the result was compared with the sum of the species 
detected. If a significant amount of arsenic remained undetected, additional digestion or assay for 
asenobetaine was performed. Detection limits for InAS, MMA, and DMA were 0.5, 1, and 2 
micrograms/L respectively. Concentrations below the detection limit were set at one half the 
detection limit. The MMA and DMA measured in this study were in the pentavalent forms. The 
trivalent forms, MMA(III) and DMA(III), are rapidly oxidized to MMA(V) and DMA(V) during 
storage  [7]. 
Ascertainment of social and demographic variables. – In India, socioeconomic status is 
commonly measured by the types of dwellings, which, in turn are correlated with household 
economic status   [15]. Hence, in this study, socioeconomic status was determined by two 
parameters: dwelling type based on materials used to construct the house and educational 
attainment. Three different dwelling types were described: pucca, indicating houses that were built 
with high quality materials, eg bricks or concrete, those constructed partially with clay and bricks 
(semi-pucca), and those that were made mainly of clay (kacha). The other indicator for 
socioeconomic indicator was educational attainment. In our study, we classified educational 
attainment in the following categories: no formal education, the respondent only attended primary 
schools and then dropped out (primary education), the respondent attended secondary schools (ie, 
had 10 years of formal education), and the respondent finished high school and achieved higher 
education (high school and above).  
Assessment of dietary variables. – Weight and height were measured, and Body Mass Index was 
calculated. Food intake was ascertained by a detailed questionnaire based on 24-hour recall. The 
"senior" woman, who in this population, directs preparing food for the family, was interveiwed. 
Raw food materials were weighed whenever the participating woman was unable to state the actual 
weight of the food used. To estimate the amount and volume of food consumed, plates and cups of 
various sizes were shown to the participating woman during the interview. Dish volumes were 
standard amounts listed by India’s National Institute of Nutrition for use in diet surveys.  
The participating woman was questioned about each meal, from the previous day’s lunch 
through the breakfast on the day of the interview. All food items used to prepare each meal were 
noted, and their weights in grams were recorded in the questionnaire. The volume of each cooked 
food was assessed by questioning the senior woman using standard cups and plates. From the total 
cooked food, the portion given to the individual participant was also assessed by cups and plates 
exhibited to the woman. Standard size spoons were used to assess the intake of sugar and oil. 
Participants who worked in the fields often carried food from home. If not, then the participant was 
questioned about purchased food items. Each participant was also questioned directly about his or 
her food likes and dislikes and asked to briefly confirm what was reported by the woman of the 
house. Questions were asked about the weekly consumption of meat, fish, eggs, milk, and fruit 
because these items were not consumed daily. A one-week intake of these food items as then 
divided by 7 to calculate the daily average intake. Individual intake in terms of raw food item (rice, 
legumes, potato) was calculated by the formula F=(P/Q)*R where F was individual intake of a raw 
food item by the study participant from a particular preparation, P was the amount in grams of the 
total raw food ingredient, F, usd for cooking this preparation, and Q was the total volume in 
milliliters of cooked food preparation consumed by the study participant. 
The total intake (24-hourly) of each nutrient (carbohydrate, protein, vitamins), and calorie 
consumption were calculated using a spreadsheet program. A detailed database was set up for the 
nutrient consumption per 100 g raw food items.  
The protein, fat, carbohydrate, energy, fiber, mineral (calcium, phosphorus, iron, and zinc), and 
vitamin (thiamin, riboflavin, niacin, vitamin B6, folate, carotene, retinol, and vitamin C 
composition of raw foods were obtained from information published by the National Institute of 
Nutrition, India. As in other countries, selenium intake in the diet is variable depending on the soil 
where food is grown. Hence, it was not possible to asess selenium intake in this study.  
Food composition (nutrition values) for ready-to-eat items (biscuits, health beverages, skimmed 
milk) were obtained from the package information. Food composition of items not typically 
prepared in homes was averaged from information obtained from the owners of five shops. Vitamin 
supplements are not used in the study population. 
Ascertainment of micronutrients. – Field physicians interviewed participants using a structured 
quesionnaire, conducted general medical examination, and obtained blood samples the same day 
participants were located. Informed consents were obtained from all participants. Nonfasting blood 
samples were obtained on 180 cases and 196 controls. Blood samples were stored in a covered chest 
(0 degree centigrade) in the field to prevent degradation of light and temperature sensitive 
compounds. Approximately half (58%) of the blood samples were centrifuged and aliquoted into 
serum and plasma samples the same day, while the rest were refrigerated overnight (4 degree 
centigrade) and aliquoted the next day. Aliquots were kept frozen at -20 degree Centigrades in 
India, delivered on dry ice, nd stored at -70 degree Centigrade in the US, until analysis.  
Laboratory methods. – Pacific Biometrics (Seattle, WA) conducted serum and plasma analyses 
for the micronutrients and biochemical indicators unless otherwise noted. Assays were conducted 
blind to the case or control status of each sample. Methods used for each nutrient are briefly 
presented. Plasma indicators measured include homocysteine, glutathione, cysteine, methionine, 
and vitamin B6. Plasma levels of retinol (Vitamin A), alpha-tocopherol (Vitamin E), alpha-carotene, 
beta-carotene, lycopene, lutein-zeaxanthin, and beta-cryptodextrin were also measured. Plasma 
thiols (homocysteine, glutathione, and cysteine) were measured by high performance liquild 
chromatography (HPLC) using an internal standard and monobromobimane derivatization. Plasma 
methionine was measured by amino acid analyzer (Beckman 6300 Amino Acid Analyzer) using a 
cation-ion exchange column at the Scientific Research Consortium, Inc. Vitamin B6 (Pyridoxal 
phosphate) was determined by HPLC and fluorescence detection involving precolumn 
derivatization of plasma vitamers with sodium bisulfite. Plasma retinol, alpha-tocopherol, beta-
carotene, lycopene, lutein/zeaxanthin, andbeta-cryptodextrin were analyzed by isocratic reverse-
phase HPLC after addition of internal standards and total lipid extraction.  
Serum measurements include glucose, cholesterol, vitamin B12, folate, transthyretin, and 
selenium. Glucose was assayed using an automated version of the Barthelmai and Czok gluose 
assay (the hexokinase/glucose-6-phosphate dehydrogenase). Total serum cholesterol was quantified 
with the CDC-standardized Trinder end-point reaction in an automated chemistry analyzer. Levels 
of vitamin B12 and folate were analyzed by CEDIA assays on the Hitachi 911 using Roche 
reagents. Transthyretin levels were determined by immunopreciptin analysis. Sample transthyretin 
concentrations were calculated from a standard curve established for each assay batch. Selenium 
was measured by graphite furnace atomic absorption spectrophotometry at the Nutrition Research 
Laboratory in the Department of Laboratory Medicine t the UUniversity of Washington or by 
inductively coupled plasma mass spectrometry at the Associated Regional and University 
Pathologists trace mineral laboratory at the University of Utah Health Science Center (Salt Lake 
City, UT).  
Statistical data analysis. –  
Dietary variables were adjusted for calorie intakes by dividing the dietary intakes by calorie 
intakes. Quintiles of calorie-adjusted dietary intakes and levels of serum micronutrients were used 
for further analysis as explanatory variables. The following outcome variables were used: 
percentages of excreted inorganic arsenic (InAs%), monomethyl arsonous and arsonic acids (MMA
%), dimethyl arsinic acids (DMA%) and MMA:DMA ratio. Covariates included age in years, 
gender, levels of education, types of housing, and total arsenic species in urine. 
One-way ANOVA (ANalysis Of VAriance) was used to test the mean differences in InAs%, 
MMA%, DMA%, and MMA:DMA ratios against age in years, gender, levels of education, types of 
housing, and quintiles of total arsenic species in urine. One-way ANOVA was also used to test the 
mean differences between highest and lowest quintiles of dietary intakes and serum micronutrients.  
Multivariate models. – Associations between dietary intakes, serum micronutrients and 
indicators of methylation were studied by several bi-, and multivariate linear regression models. In 
each of these models, the outcome variable was an indicator of methylation (InAs%, MMA%, 
DMA%, or MMA:DMA ratio), and the exposure variable was an item of dietary intake, or a serum 
micronutrient. For multivariate linear regression models, following co-variates were included: age 
in years (categorized), gender, levels of education, types of housing, and quintiles of total urinary 
arsenic species. The standardized regression coefficients and model chi-squares were compared 
between the bivariate and multivariate models to assess the impact of the covariates in the 
association between dietary, serum micronutrient, and outcome variables.  

Results 
More than 90% of the participants were less than 60 years old, and about 38% were less than 30 
years, and about 64% were male. In this population, about 30% had no formal education, and less 
than 5% population had completed high school and attained higher education beyond high school, 
and about 52% lived in kacha houses. The median percentages of excreted inorganic arsenic, MMA, 
and DMA in urine were respectively 20.7, 8.56, and 74.8, while the median MMA:DMA ratio was 
12.2 indicating high MMA output relative to DMA excretion (Table 1). 
Older age groups and male gender was associated with higher MMA% and high MMA:DMA 
ratios, while no statistically significant association was observed between educational attainment, 
type of housing and total excreted arsenic concentration in urine (Table 2). 
Low calorie-adjusted dietary intakes of niacin, but high calorie-adjusted dietary intakes of 
animal protein, animal fat, calcium, phosphate, Vitamin A, Riboflavin, Lysine, Leucinea and 
Isoleucine were associated with increased MMA excretion. Higher calorie adjusted dietary intakes 
of Vitamin A was associated with high DMA excretion (Table 3). 
Compared to those in the lowest quintiles of blood levels of glucose, folate, and selenium, those 
who were in the highest quintiles had higher percentage of inorganic arsenic in their urine. Glucose, 
folate, and selenium were also associated with decreased MMA percentages, and decreased 
MMA:DMA ratio. In summary, blood glucose, folate, and selenium were associated with increased 
unchanged inorganic arsenic excretion but reduced MMA percents and reduced MMA:DMA. These 
indicate that these three micronutrients were associated with low methylation per se. On the other 
hand, homocysteine, retinol, vitamin B6, and methionine were associated with increased MMA 
excretion, and increased MMA:DMA ratio, indicating that these were associated with high 
methylation (Table 4).  
These associations were tested in a series of bi- and multi-variate linear regressions where 
indicators of methylations were regressed on the dietary and serum micronutrients. In the 
multivariable models, the following co-variates were added to control for their effects: age in years, 
gender as indicators of their demographic profiles, and educational attainment and housing 
conditions as measures of their socioeconomic status, and total excreted arsenic content in urine 
(measure of arsenic exposure). Standardized betas were used to test the strength and direction of 
association between diet, micronutrients, and indicators of methylation. 
In the bivariate analysis, the following dietary variables were found to be statistically 
significantly associated with MMA percentages (in decreasing order of their betas): riboflavin, 
niacin, animal fat, animal protein, vitamin A, phosphates, calcium, and lysine. All of these except 
niacin, were found to increase the proportion of MMA. These effects persisted even after 
adjustment for the effects of demographic, socioeconomic factors and the effects of arsenic 
exposure. Dietary niacin was found to be negatively associated with MMA proportion, indicating 
that it was associated with reduced methylation (Table 3). 
Glucose, folate, and selenium were associated with increased inorganic arsenic excretion 
percentages and reduced MMA percentage excretion, while homocysteine and retinol were 
associated with reduced inorganic arsenic percentages and increased MMA percentages. These 
figures suggested that in crude estimates, glucose, folate, and selenium were associated with 
reduced methylation and homocysteine and retinol were associated with increased methylation 
(Table 4).  
These associations were further tested with a series of bivariate and multivariate linear 
regressions. The standardized betas obtained from these linear regression models are shown in 
Table 5 for the dietary variables, and shown in Table 6 for the serum micronutrients. For inorganic 
arsenic percentage, no dietary variable was found to have statisticially significant association. The 
following dietary variables were found to have statistically significant association with MMA%: 
animal protein, animal fat, phosphates, riboflavin, lysine, leucine, and isoleucine. For MMA%, 
unadjusted standardized beta eestimate for animal protein was 0.13; this meant that for every 3.5 g 
increment of calorie adjusted dietary intake of animal protein, MMA% in urine would increase by 
about 0.46, and after adjustment for the effects of age, gender, housing conditions, education, and 
urine arsenic levels, for every 3.5 g increment in calorie adjusted dietary intake of animal protein, 
MMA% in urine would increase by about 0.56, indicating that adjustment for demographic, 
socioeconomic, or exposure variables had very little effect on the association between dietary intake 
of animal protein and methylation (measured by MMA% output).  
As for blood micronutrients, selenium was negatively associated with increased MMA%, while 
retinol and Vitamin B6 were positively associated with increased MMA%, indicating association of 
selenium with reduced methylation and that for retinol and Vitamin B6 with increased methylation 
capacities. After adjustment for the effects of demographic, socioeconomic, and exposure level 
factors, 0.4 unit increment in serum selenium levels were associated with 0.56% reduction in MMA
% in urine. In comparison, after adjustment for demographic, socioeconomic and arsenic exposure 
factors, for every 10 microgram increment in serum retinol level, the MMA% output in urine would 
increase by about 0.6%, and for every 45 microgram/L increment in the levels of Vitamin B6, the 
MMA% in urine would go up by about 0.6%.  

Discussion 
To summarize the key findings of this study, we found that several dietary elements and serum level 
micronutrients were associated with either increased or decreased methylation, marked by the 
output of the percent MMA in urine. High dietary intakes of animal protein, animal fat, calcium, 
phosphates, Vitamin A, Riboflavin, Lysine and isoleucine, serum retinol and Vitamin B6 were 
associated with increased methylation (marked by increased MMA%), while increasing levels of 
serum selenium was associated with reduced arsenic methylation. These associations persisted even 
after adjustment for the effects of demographic and socioeconomic variables (age, gender, 
education, housing), and arsenic exposure marked by total arsenic levels in urine. 
This study was based on a cross sectional survey of over 7600 individuals within which a case 
control study was nested (N = 406). Information about dietary variables was obtained by a dietician 
and the measurement of the serum micronutrients and indicators of methylation was done at 
different places so that there remained no possibility of these results being influenced by either 
observer or other forms of bias. Further, in these analyses, demographic (age, and gender), 
socioeconomic (types of housing, education), and arsenic exposure (total urinary arsenic) were 
adjusted for in the analyses to control for possible effects of confounding factors.  
For dietary Riboflavin, Phosphates and Vitamin A, between the first (Q1) and highest quintiles 
(Q5) of dietary intakes, Inorganic arsenic%, and MMA% changed by more than 20% of their 
baseline values; similarly, for serum selenium, the change in inorganic arsenic and MMA% was 
about 20%, indicating that these dietary variables and micronutrients had strong effects on 
methylation (Tables 3 and 4). Additionally, dietary Riboflavin and serum selenium had high beta 
coefficients of linear regressions in multivariate models, indicating that dietary Riboflavin and 
Selenium had strong dose-response relationship as well.  
Earlier studies have shown association between arsenic methylation and arsenic caused skin and 
bladder cancer, and association between low dietary intakes of proteins, phosphates, calcium and 
increased likelihood of skin lesions. However, in contrast to dietary elements, no specific 
association between micronutrients and skin lesions were reported.  
Conclusion 
Arsenic methylation is a complex phenomenon with many regulatory steps involved. Some dietary 
elements and serum micronutrients may increase the methylation process, while others reduce them. 
Table 1:  Distribution of demographic, socio-economic, indicators of methylation, and total arsenic 
in urine for cases and controls 
Variable Category Cases % Controls % Sig
Age in years Matched
<20 34 45.9 40 54.1
20-39 89 49.1 93 50.8
40-59 54 46.9 61 53.1
>60 15 44.1 19 55.8
Total 192 213
Gender Matched
Female 73 48.9 76 51.1
Male 119 46.5 137 53.5
Total 192 95.5 213 100
Housing 0.40
Kacha 99 47.4 110 52.6
Pucca 30 51.7 28 48.3
Semi-pucca 63 45.7 75 54.4
Total 192 213
Education 0.14
No formal 59 50.4 58 49.5
Primary 97 48.5 103 51.5
Secondary 27 39.7 41 60.3
High School plus 9 45 11 55
Total 192 213
InAs% 0.03
>34 33 44 42 56
22.2 – 34 30 41.7 42 58.3
16.8 – 22.1 33 44 42 56.00
12.2 – 16.7 43 50.5 42 49.5




<4.26 28 40.6 42 59.4
4.26–6.57 47 52.8 43 47.2
6.58–8.37 35 45.5 43 54.5
8.38–11.2 43 50.6 43 49.4
>11.2 32 47.5 42 52.5
Total 192 213
DMA% 0.21
< 58.3 35 46.1 42 53.9
58.3–67.5 27 39.1 43 60.9
67.6–74.1 42 50 43 50
74.2–79.1 33 44 43 56





< 0.06 30 42.3 42 57.8
0.06–0.09 48 53.3 43 46.7
0.10–0.12 36 46.2 43 53.9
0.13–0.16 41 49.4 43 50.6





< 11.5 16 27.3 41 72.7
11.5–30.2 41 48.8 43 51.2
30.3–60.2 52 54.3 43 45.7
60.3–119 39 47.5 43 52.5
> 119 45 51.2 43 48.8
Total 192 213
Table 2:  Mean and interquartile ranges for InAs%, MMA%, DMA%, MMA:DMA ratios, total 
urinary arsenic, peak and average tubewell water arsenic concentrations.  
  
Table 3. Crude odds ratio between case control status and selected explanatory variables (adjusted 
for the effects of age and gender).   
Cases Conttrols
Variable Mean Q1 Q3 Mean Q1 Q3
InAs% 16.8 11.2 26.4 18.7 13.8 29.3
MMA% 7.59 5.29 10.5 7.48 4.96 10.3
DMA% 73.3 64.4 80.5 71.9 62.1 77.8
MMA:DMA ratio 0.11 0.07 0.15 0.11 0.08 0.15
Total urinary arsenic 53.6 26.3 118 43.2 14.4 93.7
Tubewell peak water conc 325 211 405 180 45 260
Tubewell av water conc 179 86 233 83 9 133
Variable Category Odds Ratio 95% Confidence Interval
Lower limit Upper limit
InAs%
> 34 1.00
22.2–34 0.90 0.46 1.74
16.8–22.1 0.99 0.51 1.90
12.2–16.7 1.30 0.70 2.44
< 12.2 1.66 0.90 3.07
MMA%
< 4.26 1.00
4.26–6.57 1.65 0.87 3.12
6.58–8.37 1.25 0.65 2.43
  
Table 4. Odds ratios adjusted for the effects of  age, gender, housing and educational attainment. 
The estimates for age, gender, housing and education are not shown here. 
8.38–11.2 1.54 0.81 2.94
>11.2 1.38 0.71 2.70
DMA%
< 58.3 1.00
58.3–67.5 0.76 0.39 1.47
67.6–74.1 1.18 0.63 2.19
74.2–79.1 0.92 0.49 1.76
>79.1 1.53 0.84 2.80
MMA:DMA Ratio
< 0.06 1.00
0.06–0.09 1.62 0.86 3.06
0.10–0.12 1.21 0.63 2.32
0.13–0.16 1.39 0.73 2.65
> 0.16 1.21 0.62 2.38
Variable Category Odds Ratio 95% confidence interval
Lower limit Upper Limit
InAs%
> 34 1.00
22.2–34 0.89 0.46 1.73
16.8–22.2 0.93 0.48 1.80
12.2–16.8 1.18 0.62 2.24
  
Table 5. Summary of the previous research on association between skin lesions and arsenic 
methylations 
< 12.2 1.51 0.81 2.83
MMA%
< 4.26 1.00
4.26–6.57 1.62 0.85 3.08
6.57–8.37 1.17 0.60 2.29
8.37–11.2 1.37 0.70 2.68
> 11.2 1.24 0.62 2.44
DMA%
< 58.3 1.00
58.3–67.5 0.76 0.39 1.47
67.5–74.1 1.08 0.57 2.05
74.1–79.1 0.86 0.45 1.65
> 79.1 1.43 0.77 2.64
MMA:DMA Ratio
< 0.06 1.00
0.06–0.09 1.55 0.81 2.96
0.10–0.12 1.16 0.60 2.26
0.13–0.16 1.28 0.66 2.49
> 0.16 1.11 0.56 2.21
Author, Year Study Type Outcomes Effect estimates
Hsueh, 1997 Cross-sectional Skin cancers MMA% <=26.7:8.35 (1.07–65.0) MMA% 
> 26.7: 23.9 (2.55–255)
  
Yu, 2000 Case control Skin lesions MMA%: 5.5 (1.22–34.8) DMA% : 3.25 
(1.06–9.97) InAs% : 3.50 (0.73–16.9)
Chen, 2003 Case Control Skin Cancer As3: 2.39(1.02–5.6) Low SMI and high 
CAE: 7.48(1.65–33.9)
CHAPTER 6: DISCUSSION AND IMPLICATIONS 
Summary of the key findings from the Arsenic study 
Summarize the three papers here in brief 
The three different studies on the inter-relationships between  
Implications for the health behavioural model 
Andresen and Newhouse (1968) proposed a model on the utilization of and access to health care 
services for individuals and families. Using national survery data, they identified three main 
determinants of health care access and utilization they termed as predisposing variables, enabling 
variables, and need variables. Predisposng variables referred to those variables that were associated 
with demographic characteristics, the enabling variables were all variables that would allow an 
individual to access health services such as regular source of income and travel arrangements (such 
as availabilit of public transport), and need variables that were either physiological/pathological or 
evaluated need that was determined by a physician or an  
The initial model proposed by Andersen underwent four phases of revisions (andersen revbehav 
paper). The final model is presented in the above figure (Figure 1). Thus, for example, in the initial 
model, there was no mention of genetic or genome based variables that might account for health 
services utilization (True and Romeis reference). This variable was added to the model 
(predisposing category). In addition, the typology was expanded to further classify different forms 
of access to care (potential versus realized access),  and need (realized versus evaluated needs). 
 
Figure 5: Diagram of the Anderson model of behavioural theory of health 
care utilization 
Figure 5 illustrates the behavioural theory of health services utilization. Andersen and Newhouse 
(1968) proposed an explanatory and a predictive model of health services utilizaiton for individuals, 
families, and population. According to this model, health services utilization as an outcome can be 
both explained and predicted by considering a range of variables. This model has undergone several 
iteration over three decades to take into account dominant paradigms of health services utilization 
(cite the 1995 paper).  
Central to the Andersen (1995) model is a typology of variables that may explain health care 
utilization and access based on their analysis of  large administrative databases. The typology was 
based on  three mutually exclusive categories pertaining to individual/population characteristics, 
organization or systems characteristics, or outcomes  and named as predisposing, enabling, and 
need variables.  
Predisposing variables are defined as  person/population-specific variables that have the property to 
affect an individual's propensity to use or access a specific type of service or make one prone (or 
not) to develop a disease or health state that would lead to uitlization of and access to health service. 
An illustrative example in the context of mental health is utilization of or access to dementia related 
service. In a model that would attempt to explain or predict what individuals/organizational 
characteristics would be more likely than others to be associated with increased utilization of 
dementia related service, an individual's age would be considered as a predisposing variable. This is 
because “dementia” by definition includes age dependent slowing down of mental processes, and 
therefore other than conditions such as progeria or Huntington's disease, older individuals are more 
likely than younger individuals to develop dementia. Therefore, it is reasonable to speculate that 
age is predisposing variable in geriatric and mental health and dementia related service utilization 
and access.  As another example,  in the context of skin lesions and utlization of dermatological 
services, one can occupation  that involves handling chemicals may be perceived as predisposing 
variables.  
Enabling variables are organizational variables. Enabling conditions make utilization/access to care 
or utilization of health services possible (or difficult to access conversely) for individuals to access 
or utlize care. Continuing with the example of dementia, an enabling variable that would be 
associated with increased access might be availability of trained geriatricians, nurses, 
gerontologists, behavioral scientists, as well as nursing homes and residential care facilities that are 
capable of taking care of elderly individuals in need of dementia care that the aged person can 
easily access. Using the example of skin lesions and dermatological services utilization, an enabling 
variable might be availability of dermatological expertise and specialist services that the patient can 
both afford and access.  
Need variables indicate the driving force or demand that an individual utlize the available service. 
For example, in case of dementia, a trigger such as agitation or another form of psychosocial 
distress may be considered as a need variable that explains why utilization has occurred for an 
individual (??). In case of skin conditions, specific lesions such as keratosis that interferes with day 
to day work or painful lesions or ulcers developing in areas of skin lesions may drive the need to 
access specialist services related to skin care (??). Andersen identified need variables as prime 
movers fo health services utilization (??). 
Figure 6: Application of results of Arsenic toxicity studies to Andersen model 
Implications for the Halfon and Hochstein model 
The life course health development  model is based on two fundamental principles – inherent 
dynamism of health as a state of being and one a state of continual development (the developmental 
perspective is brought from developmental sciences so that life is being considered as a 
continuously developing unfolding process), and the role of adaptability of an individual with 
changing environment as an individual develops in course of life (hence the term life course health 
development). The first principle is based on the premise that health is beyond a “state of physical, 
mental, and social well being”, and is a dynamic resource for everyday living (who current 
definition) and therefore, according to this model, organization of health services should be aligned 
to reflect the patter of  service utilization by individuals throughout their life span. According to this 
theory, for individuals in general, life begins at conception in the form of a fertilized egg and 
proceeds through the stages of embryo, fetus, neonate, infancy, early childhood, preschool years, 
school-age, adolescence (early, intermediate, and late), early and middle adulthood, late adulthood, 
leaving the workforce, and older age. Health at any of these stages is a complex interplay of 
environment, genes, and other societal and life-span factors and these must be taken into account 
while planning or explaining health service utilization.  
The core concepts of ages, and stages of life development are defined in terms of life trajectories, 
inteaction between micropathways, and macropathways, and adaptability of individuals with their 
environment.  The concept  of trajectories in the context of Arsenic toxicity is explained in Figure 3. 
How life trajectories evolve and develop in course of a person's exposure ot inorganic Arsenic in 
drinking water supply 
can be illustrated by considering a diagram (Figure 1). If functional state of health be plotted along 
the Y axis and the different stages of life over time be plotted along the X (horizontal) axis, it turns 
out that at least conceptually, for most persons, functional states are low in the early years of life; it 
peaks in the most productive years of life in middle and late adulthood, and then drops from the 
peak position to declining states of functionality as a person ages and enters senescence (refs). 
However, in reality, for most people, the trajectories are far more complex as there are numerous 
dimensions (not just functional capacity but there are other measurable outcomes and health states 
as well), and each of these states is sensitive to key events in life. According to Halfon et al, events 
that occur during the developmental stages of an individual can influence late life health events and 
states. Essentially these events can occur in periods when organs are developing and changes are 
irreversible (termed as critical periods, such as the first trimester of pregnancy), or there are 
windows of period during which events can impact the future course of health states of individuals 
if occur during the embryonic period (termed as : sensitive periods). There are several illustrous 
examples where events during the sensitive or critical periods have resulted in significant health 
state alterations that can be traced back to maternal health states. One example is that of the 
historical example of phocomelia (malformed limbs), other examples include vaginal 
adenocarcinoma in adolescent girls whose mothers had taken diethyl stilebesterol, malnutrition 
during pregnancy or low states of early nutrition during fetal stage predisposing a child to develop 
later diabetes (refs). Thus, dyanmic modification of life trajectories and their resultant effects can 
explain how and why individuals and populations can utilize specific health services.  
The second principle that underlies life span model of healthcare relates to the interplay between 
macro and micropathways that according to Halfon et al reflects the biological imperative of health 
services research. Micropathways are the individual biochemical and pathological pathways that 
account for disease causation and mechanisms. For example, exposure to inorganic Arsenic in 
drinking water for a prolonged period of time (exceeding six months) and in increased 
concentrations (about 10 micrograms/L of inorganic As in drinking water) can result in a process 
where inorganic As is in excess in organs like liver where they are metabolized to monomethyl 
arsonous acids and dimethyl arsinic acids and thus are soluble in urine and are excreted in kidney. 
This process involves a step that involves transfer of methyl groups from different sources. 
However, transfer of methyl group and diversion of methyl groups for the purpose of methylation of 
inorganic Arsenic can lead in turn to abnormal methylation patterns of other more life sustaining 
methylation events such as altered methylation of DNA molecules and lead to abnormal cell 
proliferation and development of cancer. This in turn is manifest in an early form as Arsenic caused 
skin lesions (Figure 5).  
In the context of environmental health, the underlying micropathway may not always be clear. 
Enviromental epidemiological studies typically unravel the roles and connections between 
micropathways and macropathways in the context of environmental health studies.  The case of 
inorganic Arsenic toxicity can be illustrated using macropathways. One possible macropathway that 
can reverse the process of micropathway and causation of skin lesions and cancer might be limiting 
or controlling access of the individual to the Arsenic contaminated water supply (??).  
[ Write something about adaptation ].  
Life course health development have formed the basis of development of measurable outcomes and 
have been applied ot develop health services programmes, but they have not been incorporated in 
explanatory or predictive model building for understanding variability of health service utilizaiton 
or access (??? write references related to this from Halfon). Therefore, if the elements of life course 
health development can be combined with a well specified model/framework such as Andersen's 
health behavioural model, the resulting model may provide a comprehensive framework to explain 
healthcare utilization and patterns of usage for not only chronic diseases, health states, but also 
enable modelling of the dynamic nature of shifting health states, health care utilization patterns, and 
used in conjunction with environmental epidemiological study findings, can provide a robust 
framework of explaining how physical, built, chemical and biological environment can impact and 
explain patterns of health service usage and delivery.  
In this paper, therefore, we propose a novel framework to explain a wide 
range of issues around health care access and utilization. We provide a 
description of the model, and use results from empirical studies to explain 
and illustrate different components of the model. In this paper, a formal 
model validation is not reported. The framework is essentially built from 
two existing frameworks, and thus, hopefully, retains the robustness of 
both models.  
In this paper, we argue that health or disease is a dynamic state where 
developmental and genetically determined health states interact with with 
environmental triggers, and individuals continally adapt and develop 
throughout their life span (diane kuh  + halfon references). Therefore, at 
any given point in time, healthe services utilization can not only be 
determined by the personal charateristics (demographic, disease 
pathological, and healthcare needs), or organizational constucts (variables 
that enable or deter) an individual's access to or utilization of health care, 
but there are other complex interplays where environmental events interact 
with individual biological systems and health outcomes are determined in 
complex ways that need careful analysis and unraveling using principles of 
environmental epidemiological studies. This “crossing point” between 
environment, health, biological imperatives and health services can be 
illustrated by considering a specific example of Arsenic toxicity and how 
individuals who live in Arsenic endemic areas and develop various 
different health effects may access or utilize available health care services.  
Inorganic Arsenic is present in the shallow aquifer layer of the 
groundwater in different countries in the world (Argentina, Chile, 
Southwestern United States, Mexico, several states of Europe, Taiwan, 
China, Ganges delta (West Bengal state of India and Bangladesh), Mekon 
Delta and several other areas of the world. Inorganic Arsenic (InAs), once 
it enters the body through drinking water (or other source – the second 
most common source of As in the environment is copper smelting 
operations), undergoes metabolism in liver and gets converted to 
methylated arsenicals that are excreted thorugh urine. When individuals 
are exposed to high concentrations of inorganic As in the environment, the 
high load of InAs leads to deranged methylation of DNA in the cellular 
nuclei and in addition, through other mechanisms that are not clear, leads 
to development of typical skin lesions (melanosis, keratosis, other types of 
pigmentation, skin cancers, and cancerous lesions in other parts of the 
body). Other than symptomatic management, there is no known effective 
pharmacological treatment for arsenic caused skin lesions, and treatment 
of As caused cancers is same as treatment of organ-specific cancerous 
lesions. The only prevention of As caused toxicity is treatment of water to 
remove As from it, or preventing susceptible individuals to access As rich 
water as drinking source; neither preventive measures are feasible for large 
population groups that are commonly affected. Given these complexities 
of environmental events , if Andersen's model of health services utilization 
and access to care were to be applied to susceptible population in either 
predicting or explaining access to care and utilization of health services (in 
this case cancer related services, or dermatological services) in As endemic 
areas, conceptually, such a model would have to include environmental 
variables in addition to individual or population specific predisposing and 
need variables that might account for population in general to access or 
utilize available healthcare services for dermatological conditions or skin 
cancers, or other cancers because the demographic profile, and the needs 
might be different from that in the other services.  Further, the role of 
enabling variables would necessarily be debatable because As toxicity is 
essentially anthropogenic, in other words, the response of health system is 
in response to organizational issues associated with Arsenic in 
groundwater as a result of human activities. Health effects of As 
(cancerous effects) may not manifest until years of continuous exposure. 
Further, in case of arsenic toxicity, empirical studies support (published 
reports and unpublished analyzed data from this dissertation project) 
suggest that intake of protein rich diet, calcium and phosphorus may be 
associated with less likelihood of Arsenic caused skin lesions (cite soma + 
craig + studies from Bangladesh + ). Finally, not all individuals would be 
equally access health care services even if they were made available 
depending on their biological propensity to methylate Arsenic. The 
capacity to methylate Arsenic and therefore protective effects or risk 
factors of Arsenic toxicity can also be modified by dietary and 
micronutrient supplementation (mention Gamble's data and unpublished 
results from this dissertation work). These indicate a need for extending 
the concepts of Andersen model and incorporate principles of life course 
health development issues in explaining how individuals access and utilize 
health services throughout their life span and how that variability can be 
incorporated.  
 
Figure 7: Diagram of the Halfon and Hochstein's model of life course 
health development 
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